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Abstract
COMMUNICATING COLORECTAL CANCER RISK TO AVERAGE RISK ADULTS:
EXAMINING THE IMPACT ON RISK PEREPTIONS AND HEALTH BEHAVIOR
INTENTIONS
By Carrie A. Miller, MPH
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2018.
Director: Maria Thomson, Ph.D.
Assistant Professor, Department of Health Behavior and Policy

Background
CRC risk can be reduced though lifestyle modification and regular screenings. Providing
CRC risk feedback that promotes preventive behaviors to those at average risk has the potential
to significantly reduce CRC morbidity and mortality.
Purpose
The purpose of this dissertation was to examine the impact of CRC risk assessment feedback
among adults aged 50-75 with no personal or family history of the disease. The specific aims
were to: (1a) test personalized (vs. generic) risk assessment feedback on individuals’ risk
perceptions and intentions to engage in three risk-reducing behaviors (e.g., physical activity, diet,
and screening); (1b) determine if the provision of CRC risk information influences breast cancer
risk perceptions and mammography intentions; (2a) examine individuals’ accuracy of perceived
lifetime risk of CRC; (2b) assess whether improved accuracy following risk assessment was
associated with changes in behavioral intentions; and finally, (3) evaluate the use of a unique
sampling procedure designed to increase diversity of survey respondents.

ix
Methods
A pre-post parallel, two arm randomized controlled trial examined the effects of providing
CRC risk assessment feedback that included lifetime risk estimates and information about CRC
risk factors that was either personalized (treatment) or generic (control). N=419 average risk
adults between the ages of 50-75 were recruited from a commercial online panel.
Results
There were no differences in risk perception between study arms. Overall participants,
perceived lifetime risk of CRC lowered at post-test and seemingly produced a spillover effect in
lowered perceived lifetime risk of breast cancer among females. CRC screening intentions
increased in both study arms and mammography intentions increased in the control arm.
Accuracy of lifetime risk improved at post-test, but was not associated with changes in intentions
to perform risk reducing behaviors. Quota sampling acquired a targeted and diverse sample
quickly and efficiently.
Conclusion
Communicating CRC risk information to average risk adults can improve CRC risk
perception accuracy and enhance colorectal and mammography screening intentions. Risk
assessment feedback did not consistently influence intentions to improve diet and physical
activity.

CHAPTER 1
INTRODUCTION
Background
Colorectal Cancer
Colorectal cancer (CRC) is the third most common cancer diagnosed in both men and
women and second leading cause of cancer deaths overall in the United States (US) [1]. Over
130,000 people will be diagnosed with CRC and approximately 50,000 will die from the disease
this year [2]. The chance that a man will develop CRC during his lifetime is 4.7%. The average
lifetime risk for men of dying from CRC is 2.0% [3]. In other words, men have a 1 in 21 chance
of being diagnosed with the disease and a 1 in 50 chance of dying from it. The average lifetime
risks are comparable for women, albeit slightly lower (4.4% and 1.8% of developing and dying
from CRC, respectively). These estimates represent average risks for men and women within the
overall U.S. population; a given individual’s actual risk of developing CRC, however, may vary
widely depending on their personal risk factors.
Any attribute, characteristic, or exposure of an individual that increases the likelihood of
developing a disease is known as a risk factor [4]. Risk factors are classified as either modifiable
or non-modifiable. Non-modifiable risk factors for CRC include demographic characteristics
such as age, race, and medical history. For example, the risk of CRC increases with age.
Compared to younger aged individuals, the likelihood of developing CRC increases markedly
among people aged 45-54 years and older, and is most frequently diagnosed among those aged
65-74 years [1]. CRC is more prevalent among men than women and among African Americans
[5]. CRC risk is also greater among those with a personal medical history of adenomatous polyps
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(adenomas) or an inflammatory bowel disease (IBD), including ulcerative colitis or Crohn’s
disease [6]. A familial history of CRC, adenomatous polyps, or other inherited (genetic)
syndromes are also risk factors [7]. Although an individual cannot alter their risk based on
demographic characteristics, other known factors associated with CRC risk are modifiable.
Epidemiological studies have identified many modifiable factors that influence CRC risk,
including lifestyle-related and behavioral characteristics. Specifically, physical inactivity, being
overweight or obese, smoking, heavy drinking, and/or certain diets (e.g., high consumption of
red and/or processed meats) are associated with an increased risk of CRC [5, 7, 8]. Factors
associated with a reduced risk of CRC include a healthy diet including an adequate intake of
dietary fiber and folate, fruit, vegetables, and/or dairy products, as well as certain medications
(e.g., aspirin and hormonal treatments) [5].
Colorectal Cancer Risk-Reducing Behaviors
Changes in health behavior can substantially reduce CRC incidence and the associated
disease morbidity and mortality. The previously described lifestyle and behavioral risk factors
can become risk-reducing factors if modified appropriately. For example, steps to reduce the risk
of CRC include the following: maintaining a healthy weight; being physically active; consuming
a healthy diet; limiting alcohol consumption; and avoiding tobacco products [5]. In addition to
the management of risk factors, CRC screening is an important risk-reducing behavior.
Screening can prevent disease development through the detection and removal of precancerous
lesions [9]. Accordingly, U.S. evidence-based guidelines recommend routine screening for all
adults age 50-75 years old [10].1 The association between modifiable factors and disease risk is
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strong; in fact, as much as 70% of CRC cases could be prevented through lifestyle modification
and widespread screening [11].
Despite the potential health benefits, most Americans do not engage in a healthy lifestyle.
Behavioral risk factors associated with cancer are prevalent in the U.S. general population [12].
For example, almost 80% of American adults do not meet guidelines for physical activity [13].
Sedentary lifestyles combined with an unhealthy diet have led to a dramatic increase in the
prevalence of obesity and overweight in the US. As of 2010, two out of three American adults
are either overweight or obese [14]. In addition, national CRC screening rates are also
suboptimal; over a third of the age-eligible population remain unscreened [15]. The identification
and communication of an individual’s modifiable risk factors may be an imperative first step in
promoting risk-reducing behaviors. However, increased knowledge is not sufficient for
behavioral change [16]; improved strategies to promote CRC screening and healthy lifestyles are
needed. Specifically, how best to leverage risk factor information to engage people in cancer
risk-reducing behaviors remains unknown.
Risk and Risk Presentation
Risk is a concept based on probability; disease risk is the chance that a disease will occur
[11]. The term also that implies one possible outcome is negative and that there is some degree
of uncertainty as to what the outcome will be [17]. Risk is often expressed in absolute or relative
terms. Absolute risk is the chance of disease occurrence over a specific period of time (e.g., 5year, lifetime, etc.), while relative risk (also known as comparative risk), refers to an individual’s
risk compared to a reference group (e.g., peers). Absolute and relative risks have traditionally
been expressed either numerically (e.g., a 0% to 100% chance) or verbally (e.g., low risk).
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Although both absolute and relative risk estimates can be presented in numbers, the resulting
representations of risk are quite different. For example, a small increase in the average lifetime
risk for CRC (e.g., 4% to 6%) appears much larger when presented using relative risk (e.g., 50%
increased risk). For this reason, researchers recommend using absolute risk instead of relative
risk to improve the understanding of quantitative risk information [18]. Nonetheless, presenting
relative risk may be critical when the goal is to heighten risk perception, which is often the case
in behavioral health interventions.
The interpretation of risk information is further complicated by individual factors related to
education, health literacy, and numeracy [19]. In fact, approximately two thirds of Americans
aged 16 to 65 years do not have the level of numeric proficiency necessary to understand
proportions expressed in verbal or numerical form or to interpret basic statistics [20]. In order to
facilitate the interpretation of risk information, quantitative risk estimates are sometimes
collapsed into categories and expressed in words instead (e.g., average vs. elevated risk).
However, this broad representation of risk is less precise than numeric estimates and issues with
interpretation persist since verbal expressions of risk such as “likely” or “elevated” can be
interpreted in a variety of ways. Recent research has suggested that the presentation of risk in
visual formats (e.g., pictographs, pie charts, and stick figures) aids in the comprehension and
recall of risk information [21-23]. However, little is known about the effectiveness of using
visuals to communicate risk of low probability events [21].
In summary, there is no “one-size-fits-all” best practice for the dissemination of risk
information. A personalized approach to risk communication may be best for comprehension
accuracy, but identifying the right presentation format for a given individual can be challenging
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[17, 24]. Therefore, strategies to communicate risk effectively include presenting risk
information in multiple formats (e.g., texts, tables, and graphics) [18].
Risk Perception, Behavior Change Intentions, and Behavior
Risk perception refers to an individual’s beliefs about the likelihood of an occurrence of a
particular health threat or the likelihood of developing a health problem [25]. Previous research
has identified numerous influences that shape risk perceptions, including demographic (e.g., age
[26] and race/ethnicity [27-28]), health [26-27], cognitive (e.g., numeracy), and
psychological/affective (e.g., optimistic bias and cancer worry [26]) factors. Although a myriad
of other factors influencing risk perception have been identified in the literature, research
findings are not always consistent. For example, minorities report lower perceptions of cancer
risk than Whites in some studies [28-29], while others study have found significant variation in
risk perceptions by race/ethnicity [30-31]. The interplay between factors is also important. For
example, minorities and older adults tend to have lower numeracy, and numeracy, in turn, can
impact one’s ability to comprehend risk information [32]. The examination of these complex
relationships, differences in research methodologies, such as the type of risk variable evaluated
(e.g., absolute vs. relative), composition of study populations, and range of predictors assessed,
make it difficult to draw conclusions across studies. Despite these differences, one factor is
consistently identified in the literature; family history.
Perceptions of disease risk, including CRC risk, are heavily influenced by a family history
of the disease [26, 27, 33]. Recent research has even suggested that a family history of cancer
may lead to “spillover” effects of altering the perception of risk for other types of cancer [34].
However, the majority of new CRC cases will develop among “average risk” individuals, those
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with no known family history or other predisposing conditions (e.g., familial adenomatous
polyposis (FAP) and hereditary non-polyposis colorectal cancer (HNPCC), among others) [35].
Focusing CRC prevention strategies on average risk individuals could impact incidence and also
potentially benefit the significant portion of individuals who are unaware of their increased risk
status due to having limited or incorrect knowledge of their family health history [36]. Therefore,
research examining the factors that influence risk perception among an average risk population is
warranted but has received relatively little attention in the literature.
Risk perception and related constructs (e.g., perceived vulnerability, susceptibility, and
probability) have been prominent components of behavioral health theories for decades [25].
Widely known theories emphasizing the role of risk perception in influencing behavior include
the Health Belief Model [37], the Protection Motivation Theory [38] and the Precaution
Adoption Process Model [39-40]. Other more complex theories have been developed to predict
response to health risk information specifically, Marteau and Weinman’s adaptation of the
Common Sense Model (CSM) of Illness Representation [41]. According to this model, health
risk information is processed through an individual’s cognitive and emotional schemas. These
representations of the health threat then influence the development of coping responses (e.g.,
behavioral change) to reduce the perceived threat. Within most individual-level theories of health
behavior change, risk perception serves as a precursor of health-protective behavior change.
Specifically, increased perception of risk serves as a catalyst to increase the likelihood of the
performance of behaviors to reduce risk. From this perspective, behavioral change intentions are
a prerequisite for behavior change. Although discrepancies between intention and behavior can
occur [42], cancer screening intentions and attending screening are often correlated [43]. The
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present study will focus on behavioral intentions, as assessment of behavior change is outside the
scope this study.
The perceived risk of CRC is low among the U.S. adult population [26, 44-45]. For
example, 62% of the 2003 Health Information National Trends Survey (HINTS) respondents
aged 45 and older with no personal history of CRC indicated their CRC risk was somewhat or
very low, while far less endorsed being at moderate (30%) or somewhat high/very high risk (8%)
[26]. Based on these empirical findings and the aforementioned theoretical conceptualizations
(e.g., the Health Belief Model, etc.) of risk perception, behavioral interventions often focus on
increasing individuals’ perceptions of risk. The purported positive association between perceived
risk and risk-reducing behavior is generally supported, albeit often with relatively small effect
sizes [46-48]. A recent meta-analysis of experimental studies, however, found that heightening
risk appraisals (a composite variable comprised largely of perceived risk) had a medium effect
on behavioral outcomes overall (d+ = 0.31 (k = 217), with larger effect sizes observed for dietary
behaviors (d+ = 0.46 (k = 11) and exercise (d+ = 0.38 (k = 8) [49] – both modifiable lifestyle
characteristics and key factors in cancer prevention [50]. In contrast, at least one study using
cross-sectional, nationally representative data found no associations between perceived cancer
risk and diet and exercise behaviors [51].
Among research on CRC screening behavior specifically, risk perception generally seems to
encourage preventive behaviors as predicted by theories of health behavior. For example, a
seminal review by Vernon and a more recent analysis of cross-sectional, nationally
representative data, provide evidence that individuals who report greater perceived risk of CRC
are more likely to screen than those who report lower CRC perceived risk [52-53]. Similarly, a
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recent systematic review and meta-analysis of 58 studies by Atkinson and colleagues observed a
small, positive, and statistically significant relationship between CRC risk perception and
screening use [54].
In addition to examining CRC behavioral intentions following the provision of risk
estimates for colorectal cancer, the proposed study will assess change in women’s breast cancer
risk perceptions and mammography screening intentions. Previous research has identified
“spillover” effects where a family history of one cancer was associated with altered risk
perception for another [34]. However, it is not known whether cancer-specific risk results could
produce similar effects on the perceptions of risk and screening intentions for other cancer types
that share similar lifestyle based modifiable risk factors. This information could have important
implications for cancer risk assessments.
In conclusion, the equivocal findings related to CRC risk perception and behaviors overall
may be due, in part, to a variety of factors such as disparate measures of perceived risk and
issues related to risk perception accuracy. There is no “gold standard” instrument for assessing
risk perception [55]. Although a new, multidimensional measure of risk perception was
published in 2016 [56], the most commonly used measures consist of relatively few, face-valid
questions, such as the HINTS survey items. In fact, the majority of the 58 studies reviewed in a
recent meta-analysis of the literature examining risk perception and CRC screening measured
CRC risk perception using a single item (64%) [54]. Moreover, type of risk used in the research
reviewed was most often expressed verbally in relative (36%) or absolute (36%) terms, with far
fewer studies employing numeric absolute or a combination of risk types (7 and 21%,
respectively). Some experts assert that there are likely at least two dual processes at play in the
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comprehension of risk information (e.g., cognitive/analytical/deliberative vs.
affective/experiential/intuitive) [27, 57-59]. However, it has been noted that the affective system
is likely to be more relevant among individuals with either a family history or symptoms of
disease, compared to average risk groups [27]. Different measurements could also be the source
of biased judgments about risk perceptions. For example, laypeople have been shown to
overestimate their risk when assessing their CRC risk using numeric scales [60]; thus, categorical
response options may be preferable. Alternatively, inaccurate risk perceptions present in research
samples may be a reflection of the underlying difficulties laypeople have in the comprehension
of numeric risk information related to numeracy. Providing cancer risk information may help
correct risk perception inaccuracies and subsequently, drive intentions for preventive health
behaviors more uniformly.
Cancer Risk Assessment Tools
As our understanding of cancer etiology and risk factors has advanced, growing numbers of
risk estimation/prediction models and assessment tools, hereafter referred to jointly as risk
assessment tools (RATs), have been developed to predict the occurrence of cancer and guide
approaches to disease prevention [61]. RATs calculate an individual’s cumulative risk from
multiple sources, including individual characteristics and behaviors, family history, and
population-based estimates. A well-known use of RATs is to help clinicians identify individuals
who are at high risk of cancer and thus enable risk-stratified recommendations for screening and
disease prevention.
Three recent reviews have been published summarizing the extant CRC RATs [50, 62-64].
Although specific model evaluations are beyond the scope of this study, the discriminatory
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power of CRC RATs in general is regarded as comparable to other cancer risk models. There is
heterogeneity among RATs in the array of risk factors included, sources of data used in model
development (e.g., cohort vs. case-control studies), and outcomes predicted (e.g., subtypes of
CRC). Moreover, most have not been validated in diverse populations. There is no single best
RAT; each has unique strengths and limitations and provides varying risk types (e.g., absolute or
relative) and presentation formats (e.g., with or without visuals). A content analysis of available
internet-based cancer RATs was conducted in 2009 [65]. Among the 47 RATs identified, 10
(21%) provided colorectal cancer risk information. Among all websites providing assessments,
very few used risk communication formats that facilitate comprehension and reduce bias. For
example, while the majority of sites were intended for lay audiences (89%), 83% contained
undefined terminology (e.g., biopsy); and only five websites used both words and numbers to
communicate risk. However, approximately one-third of sites provided at least one visual
display, and one-half provided duration of risk (e.g., 5-year risk). This study suggests that online
RATs have room to improve in conveying health risks. Despite these shortcomings, cancer
RATs are becoming increasingly available to the public via online sources.
Online Colorectal Cancer Risk Assessment Tools
Among the several CRC RATs available online [66-70], perhaps the two most well-known
are those developed by the Harvard Center for Cancer Prevention [70] and the tool made
publically available by the NCI [67]. Both are easily accessible and frequently used in clinical
and research settings. The tool that began as the Harvard Cancer Risk Index (HCRI), now
available on the Your Disease Risk site [70], was one of the first calculators developed to predict
individual cancer risk [71]. The current, easy-to-use online Your Disease Risk RAT predicts
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relative risk; providing results in both verbal categories (e.g., below average) and a graphic
representation. The HCRI also provides feedback on the risk-reducing behaviors respondents are
already doing and specifies behaviors they could do to lower their risk. HCRI results, however,
do not provide numeric risk estimates, which is a recommended format for communicating risk
[18]. The NCI’s Colorectal Cancer Risk Assessment Tool (CCRAT) [67] was developed by
Freedman and colleagues [72-73]. Results of this internet-based tool provide multiple numeric
risk estimates and in addition, an invariant, bulleted summary of factors that can increase and
lower CRC risk. The factors appearing on the list are not based on assessment responses and
thus, may not apply to every respondent. For example, obesity is listed as risk factor, regardless
of whether the respondent is normal weight, overweight, or obese.
Although RATs are widely used in clinical practice, little is known about how risk feedback
affects average risk individuals and those who access these tools online. Since the perceived risk
of CRC is low in the general population [26, 44-45], RAT results that afford even average risk
estimates could conceivably help individuals gauge their risk more accurately and motivate
preventive health behaviors. However, little is known about the application of cancer risk
prediction models for population approaches to cancer prevention or the use and utility of online
cancer RATs among laypeople. A 2004 NCI-sponsored workshop on cancer risk prediction
models highlighted their potential utility to facilitate both high risk and population level
approaches to cancer prevention [61]. Workshop participants specifically expressed that since
most cancers occur among individuals with approximately average individual risk, strategies for
reducing lifestyle risk factor prevalence in the general population would yield maximum
benefits. They also called for future research on how to effectively communicate risk to the
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general public outside of the doctor-patient encounter. Additional research is needed to
determine if the provision of RAT results will similarly alter risk perception among average risk
individuals (e.g., excluding those with a family history of CRC in additional to those with a
personal history) and whether RAT results influence cancer control-related behavioral intentions,
including diet, physical activity, and screening.
To my knowledge, only one study has examined the impact of CCRAT risk information on
interest in CRC screening among lay individuals [74]. This study by Han and colleagues
included a convenience sample of adults aged 51 years and older from the general public who
accessed a website with a fully functional replica of the CCRAT. Although no main effects were
found between CRC risk information and interest in screening, results revealed different interest
in CRC screening subgroups, depending on prior screening history, estimated cancer risk, and
baseline screening interest. CCRAT results provided in this study did not include the nonquantitative, risk factor summary section. Therefore, it is unclear whether additional information
on risk factors could impact interest in risk-reducing behavior. A 2006 Cochrane review
concluded that personalized risk information mobilizes health behavior change [75]. Therefore,
the utility of the CCRAT is potentially limited since the risk factor summary it provides is not
personalized.
The addition of personalized feedback on an individual’s risk factors and related lifestyle
changes that would reduce their risk may help improve awareness related to cancer prevention
within the general population, including the roughly 32 million Americans who believe nothing
can reduce an individual’s cancer risk [76]. In addition to increasing awareness about risk
factors, the utility of the CCRAT may be enhanced as the use of individually-tailored behavior
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change information during a health risk assessment has previously been shown to promote health
behaviors [77]. Risk assessment results providing both numeric risk estimates similar to the
CCRAT and concrete, actionable behavior change recommendations corresponding to each risk
factor, such as those provided by the Your Disease Risk tool, may produce more meaningful
feedback. This may be especially true for average risk individuals, for whom no intensified
preventive approaches apply. However, it is not known what, if any, beneficial changes in risk
perceptions and intentions for behavioral change would result from this integrated format of risk
factor feedback. The current study will explore this question and address this gap in knowledge
needed to inform the future development and improvement of CRC RATs.
Conceptual Framework
The overarching conceptual framework guiding this study draws from the Common Sense
Model (CSM) of self-regulation of health and illness [78]. This longstanding theoretical model
has been used to understand the impact of risk information related to a health threat (instead of
an illness) [79-80]. Consistent with other research [79], the cognitive processing components of
the CSM (i.e., stimuli, representation of health threat, and coping) are conceptualized as risk
information, risk perception, and behavioral intentions.
As shown in Figure 1, the communication of risk information influences risk perceptions,
which in turn, drive behavioral intentions to manage risk. Specifically, it is theorized that
information about risk that is tailored to an individual’s actual risk factors and provides a
personalized behavior change recommendation to reduce risk will heighten risk perceptions and
subsequently, result in greater health behavior change intentions (compared to generic
information) [81-82]. Knowledge and saliency of risk factors are depicted as influencing
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(moderating) risk perception following the receipt of risk information, and attitudes (perceived
consequences) and behavioral beliefs (perceived controllability) about cancer prevention are
conceptualized as moderating factors between risk perception and behavioral intentions. In
addition, numeracy and self-efficacy are included in the framework and will be controlled for in
the final analyses.2
Figure 1a. Overarching Conceptual Framework

Within the treatment arm specifically, in which the risk factor summary is tailored to the
individuals’ actual risk factors and provides a personalized behavior change recommendation to
reduce cancer risk, the hypothesized pathways of causal mechanisms are shown in Figure 1b
below in red arrows. First, the provision of personalized risk information is expected to increase
knowledge about cancer prevention and saliency of risk factors significantly, compared to the
generic feedback provided in control arm (a). Higher levels of risk factor knowledge and
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saliency will subsequently enhance risk perceptions (b). Previous research supports the assertion
that tailored messages are considered more relevant and result in greater health behavior change,
compared to generic communication. In addition, increased knowledge on how to reduce risk
will logically alter attitudes and beliefs about cancer prevention (perceived consequences and
controllability) (c). Finally, more informed attitudes and beliefs about cancer prevention will
then promote higher behavior change intentions when combined with already heightened risk
perceptions (d).
Figure 1b. Conceptual Framework: Treatment Arm

Research Aims
The primary focus of the present dissertation was to examine the impact of CRA feedback
on CRC risk perceptions (primary outcome) and behavioral intentions (secondary outcome)
among an average risk adult population. This research builds on previous risk communication
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studies suggesting that personalized information about risk factors is more effective than generic,
non-personalized information in enhancing risk perception accuracy [60, 83] and cancer
screening utilization [75, 84]. The specific aims of the primary paper of this dissertation were as
follows:

Aim 1: Experimentally evaluate the effects of providing personalized (vs. generic)
information on CRC risk factors on risk perceptions and behavioral intentions among an
average risk adult population.
Hypothesis 1: Risk perceptions will be higher among those who receive
personalized information, compared to generic.
Hypothesis 2: Behavior change intentions will be higher among those who receive
personalized information, compared to generic.
Aim 2: Explore whether the provision of CRC risk information alters breast cancer risk
perceptions and mammography screening intentions among female participants.
Hypothesis 3: Breast cancer risk perception will be higher among those who
receive personalized information, compared to generic.
Hypothesis 4: Mammography screening intentions will be higher among those
who receive personalized information, compared to generic.

The existing body of research on CRAs has shown improved risk perception accuracy
following risk assessment feedback [60, 83, 85-86]. However, few studies have evaluated the
impact of CRA feedback on average risk individuals (i.e., individuals with no known history of
CRC). Advanced approaches to CRC prevention including strategies aimed at the entire at-risk
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population may be particularly important given the high prevalence of modifiable risk factors in
the general population and because intervening with the populace would yield more cumulative
benefits than focusing on those at high risk alone. Since perceived risk of CRC is low [26, 44-45]
and the actual risk of CRC of someone at average risk is relatively low, it is unclear if improving
risk perception accuracy would be beneficial (e.g., promote risk reducing behaviors) or
detrimental (i.e., foster a false sense of security that hinders the adoption of preventive
behaviors). Thus, research is needed to assess factors associated with post-CRA lifetime risk
perception accuracy and the behavioral implications of altering accuracy among average risk
individuals. Accordingly, the second paper of this dissertation addressed this gap in knowledge
through the following aims:

Aim 1: Characterize perceived lifetime risk prior to CRA feedback.
Aim 2: Examine predictors of baseline perceived lifetime risk accuracy.
Aim 3: Identify predictors of improved risk perceptions among those who were
inaccurate at baseline.
Aim 4: Assess whether improvement in perceived lifetime risk accuracy was associated
with changes in behavior change intentions for physical activity, diet and attending CRC
screening.

In addition to these research aims, this dissertation sought to characterize the validity of the
online panel sample utilized in the present research. Understanding the strengths and potential
pitfalls of using online panels is critical to making informed decisions about research strategies,
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especially when targeting groups typically underrepresented in research samples, such as
minorities and older adults. Thus, the specific aims of the final paper were to:

Aim 1: Describe the recruitment and participant flow of a survey administered by a
commercial research platform using quota sampling.
Aim 2: Describe the sociodemographic characteristics of eligible respondents that
complete the survey and respondents that initiate, but do not complete the survey.
Aim 3: Compare sociodemographic profiles of survey completers to respondents that
initiate, but do not complete the survey.
Aim 4: Determine when study-eligible non-completers exit the survey.

Results of this dissertation afforded valuable insights into the potential utility of CRAs to
alter risk perceptions and drive risk-reducing behaviors. Findings provided insight regarding
which participants benefited from improved accuracy after receiving CRA feedback and how
behavioral intentions were impacted as a result of improved accuracy. The sampling methods
used in this study were also examined. Such information is imperative to the improvement and
development of the next generation of CRA tools, as well as to the design of interventions to
improve cancer preventive behaviors.
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Footnotes
1
CRC screening guidance referenced in this study was based on that provided by the U.S.
Preventive Services Task Force, which remains the same at the time of this dissertation
draft. However, it should be acknowledged that the American Cancer Society updated
their guidelines in 2018, recommending that those at average risk of CRC should screen
regularly between the ages of 45-75 years old – five years earlier [87].
2
Intervention arm (generic vs. personalized) was not a significant predictor of either risk
perceptions or behavioral intentions in multivariate analyses controlling for the other
variables in the model. There were also no significant differences in risk perception or
other intermediate variables between intervention groups. Subsequently, the moderating
relationships proposed in this model, illustrating a causal pathway, were not warranted.
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CHAPTER 2
Paper One
THE EFFECTS OF PERSONALIZING COLORECTAL CANCER RISK COMMUNICATION
ON RISK PERCEPTIONS AND HEALTH BEHAVIOR INTENTIONS: A RANDOMIZED
TRIAL OF AVERAGE RISK ADULTS
Abstract
Background
Risk assessment tools may help individuals gauge cancer risk and motivate lifestyle changes
and other risk-reducing behaviors, such as routine cancer screenings. Despite the evermore
common availability of such tools, little is known about the potential utility of risk assessment
tools for population approaches to cancer prevention.
Purpose
We evaluated the effects of providing personalized (vs. generic) colorectal cancer (CRC)
risk assessment feedback on average-risk individual’s risk perceptions and intentions to engage
in three risk-reducing behaviors: CRC screening, diet, and physical activity. We also examined
whether the provision of CRC risk assessment information alters breast cancer risk perceptions
and mammography intentions.
Methods
We administered an accepted cancer risk assessment tool to an online panel sample. N=419
survey respondents aged 50-75 with no personal or family history of CRC were randomized to
receive lifetime CRC risk estimates and risk factor information that was either personalized
(treatment) or invariant/non-personalized (control). Respondent cancer risk perceptions and
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behavioral intentions were ascertained immediately before and after risk assessment
administration.
Results
No differences were observed in risk perception or behavioral intentions between groups.
However, CRC screening intentions and intentions to talk to a doctor about CRC screening
significantly increased in both groups. In addition, within both groups, the average lifetime risk
of colorectal and breast cancers reported significantly decreased.
Conclusion
Results support the potential role cancer risk assessment information could play in
promoting cancer screening behaviors, while highlighting the known difficulty of using risk
information alone to “moving the needle” on lifestyle modifications among individuals without a
cancer history. Reductions in perceived lifetime risk of CRC seemed to spillover onto female
participants’ perceived lifetime risk of breast cancer. How best to leverage benefits from (while
minimizing negative impact of) the spillover effects from risk communication targeting one
disease on other disease warrants additional consideration.
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Background
Colorectal cancer (CRC) is the third most common cancer and second leading cause of
cancer death overall in the United States (US) [1]. Over 130,000 people will be diagnosed with
CRC and approximately 50,000 will die from the disease this year [2]. The majority of new CRC
cases will develop among “average risk” individuals, those with no known family history or
other predisposing conditions (e.g., familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC)) [3]. The association between modifiable factors and CRC
risk is strong; as much as 70% of CRC cases could be prevented through lifestyle modification
and widespread screening [4]. Therefore, modifying behavioral risk factors within the average
risk population could substantially reduce CRC incidence and associated morbidity and
mortality.
Lifestyle factors such as maintaining a healthy weight, being physically active, consuming a
healthy diet, limiting alcohol consumption, and avoiding tobacco products can reduce the risk of
CRC [5-6]. CRC screening is another important risk-reducing behavior as it can prevent disease
development through the detection and removal of precancerous lesions [6-8]. Despite the
potential health benefits, most Americans do not engage in CRC risk-reducing behaviors.
Lifestyle risk factors associated with cancer are prevalent in the U.S. general population [9-10].
The identification and communication of an individual’s modifiable risk factors may help
individuals gauge their CRC risk and motivate intentions to engage in lifestyle and other riskreducing behaviors, such as routine cancer screenings. Cancer risk assessment tools that convey
this information are increasingly available to the public online [11]. Although evidence suggests
online risk assessment tools are a promising approach for communicating risk and promoting
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health behaviors in high risk individuals [12-14], little is known about the application of cancer
risk assessments for population approaches to cancer prevention among those at average risk.
Another unknown outcome of cancer risk assessments is what influence, if any, receiving
risk information for a specific cancer type has on risk perceptions and behavioral intentions
related to another cancer type. An earlier study by Rubinstein and colleagues identified “novel
spillover effects” whereby having a family history of one cancer was associated with altered
disease perceptions of another cancer type [15]. Therefore, it is conceivable that heightened
perceived risk for one cancer (following receipt of risk assessment results for that cancer type)
may alter an individual’s perceived risk and behavioral intentions related to another type of
cancer (via spillover effects). Therefore, conceptually, a single intervention could be designed to
improve multiple risk behaviors. This hypothesis has not been scientifically evaluated.
While communicating risk may be an important step in shaping perceptions of disease risk,
providing risk estimates alone may not be enough to drive health behaviors and behavior change
intentions [16-22]. This may be especially true among individuals without a known family
history who receive low or average numeric (e.g., <5%) or categorical (e.g., “unelevated”) risk
estimates. When targeting individuals who do not have a known family history of cancer, it may
be particularly important to increase information saliency by incorporating personalized
information designed to heighten risk perception, and ultimately, drive behavioral change
intentions.
Personalized risk communication, including information tailored to individuals’ unique risk
factors has been shown to increase accuracy of risk perceptions [23-24] and mobilize cancer
screening utilization [25-26]. Another study similarly found improvements in breast cancer risk
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perceptions and physical activity intentions within the personalized condition (compared to nonpersonalized) [27]. To our knowledge, no study has compared the effects of providing CRC risk
feedback with personalized feedback (compared to generic) regarding risk factors, in addition to
personalized risk estimates (e.g., lifetime risk), on behavioral intentions as well as risk
perceptions among average risk individuals.
The primary objective of this study was to experimentally evaluate the effects of providing
personalized (vs. generic) information on CRC risk factors on risk perceptions and behavioral
intentions among an average risk adult population. In secondary analyses, we also explore
whether the provision CRC risk information alters breast cancer risk perceptions and
mammography screening intentions among female participants. Consistent with the evidence
favoring personalized risk communication [28], the primary hypothesis of this study was that
(H1) CRC risk perception will be higher among those receiving personalized information,
compared to the control. Secondary hypotheses also assessed were that compared to controls,
(H2) behavior change intentions regarding CRC screening, healthy diet, and physical activity
will be higher among treatment participants; and among female participants, (H3) breast cancer
risk perception and (H4) mammography screening intentions will be higher among treatment
participants.
Methods
Study Design
We used a pre-post parallel trial design to evaluate the effect of providing personalized risk
factor information. An online survey was administered through Qualtrics, an internet-based
survey and research company, in June 2017. Participants were randomized to receive either
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personalized or generic information on risk factors. Randomization occurred after completing
screener items and the pre-intervention survey but prior to the post-intervention survey and
remaining demographic items (e.g., marital status, education attainment, and employment status).
Randomization was carried out by Qualtrics using the Mersenne Twister algorithm, a commonly
used and widely accepted form of random number generation [29-30].
Participant responses to risk perception and behavioral intention questions were collected
prior to and immediately following receipt of CRC-specific risk feedback. Prior to beginning the
risk assessment tool, participants were queried for information necessary to determine sample
eligibility (e.g., age, race, household income, state of residence, and personal and family cancer
history), and asked to complete a brief series of questions measuring sociodemographic
characteristics including gender, education attainment, marital status, employment status, and
insurance status. Baseline (pre-intervention) behaviors were queried to ascertain cancer
screening status and to detect the presence of lifestyle risk factors (physical activity and diet)
using previously developed items [31-33]. All survey items required a response; therefore, there
were no skipped or missing responses. Upon survey completion, participants could select from a
variety of incentive options worth approximately $5.00. This study was approved by an
Institutional Review Board (IRB) following expedited review.
Sample and Survey Administration
Qualtrics acquired the sample from existing pools of research panel participants.1
Recruitment targeted potential survey respondents who were likely to qualify based on the
demographic characteristics reported in their user profiles (i.e., race and age). Panelists were
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invited to participate via email and opted in by activating a survey link that directed them to the
study consent form.
Quota sampling was used to obtain a sample that was diverse with respect to household
income and race. A balanced sample of White, Black/African American, and
Hispanic/Latino/Spanish participants was requested. Respondents identifying as some other race
were not eligible to participate. Eligible panel participants included residents of the contiguous
U.S. with the ability to read and comprehend English language. In addition, participants were
screened for the following eligibility criteria: age 50-75 years old (age-eligible for CRC
screening) and no personal or family history of CRC or other predisposing factor (i.e.
inflammatory bowel disease, polyps or a hereditary syndrome such as familial adenomatous
polyposis (FAP) or hereditary nonpolyposis colon cancer (HNPCC), also known as Lynch
Syndrome). Individuals who reported an age outside the range of 50-75 years or any
predisposing factor were excluded. In addition, respondents were removed from the survey if
they responded incorrectly to any of the three “attention checks” (i.e., survey items that
instructed respondents to provide a specific response).
Risk Information
All participants, regardless of study arm, received gender-specific, population-level lifetime
risk of developing CRC in the United States (Figure 1) [34]. Risk factor information was
presented immediately following the numeric risk estimates, according to study group.
Participants randomized to the control group received a summary describing 11 factors that can
increase and lower risk of CRC (Figure 2) [35-36]. Within the treatment group, the risk factor
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information provided was tailored to each respondent’s actual risk profile (i.e., the
presence/absence of risk factors as reported by each respondent).
To test the influence of personalized risk factor information on risk perception and
behavioral intentions, three modifiable CRC risk-reducing behaviors were chosen (screening,
physical activity, and diet). The specific content of the individually tailored risk summary was
adapted from the prevention messages provided by existing online risk assessment tools [35, 3738]. Each targeted behavior was framed as either a risk (Figure 3a) or protective (Figure 3b)
factor based on participant reported engagement in that behavior. Any behaviors listed as a risk
factor included a behavior change recommendation. Each risk factor message also included
information about the consequences of the behavior (i.e., performing this behavior will reduce
risk). The wording of these statements was developed based on Prospect Theory [39] and in
accordance with prior research demonstrating that gain-framed messages tend to be more
effective in promoting prevention behaviors and intentions, including diet [40] and physical
activity [41], whereas loss-framed behaviors are more effective in promoting diagnostic
behaviors and intentions (e.g., cancer screenings) [42-43]. Table 1 provides the protective and
risk message content corresponding to each of the three behaviors.
Outcome Measures
Cancer Risk Perceptions.
The primary outcome, CRC numeric lifetime risk, was assessed by asking, “On a scale from
0 to 100 %, how would you rate the probability that you will develop colorectal cancer in the
future?” with an open-response of 0-100%. “How likely is it that you will get colorectal cancer at
some point in the future?” was used to assess absolute risk using a five-point Likert scale ranging
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from “very unlikely” to “very likely.” Relative risk was also measured with the question, “How
do you think your chance of developing colorectal cancer in the future compares to the average
person of your gender and age?” with responses ranging from “much lower” to “much higher”
on a five-point Likert scale. These three individual items were also adapted to assess perceived
absolute, relative, and numeric lifetime risk of breast cancer among female participants.
Dichotomous measures of accuracy were created for reported numeric lifetime risk of
colorectal and breast cancers. Accurate lifetime risk of CRC was defined using statistics from the
American Cancer Society [2], as a response between four and five percent. The average lifetime
risk of women developing breast cancer is approximately 12% [44]; therefore, responses
between 10-15% were coded as accurate. The wider range of reported breast cancer risk was
considered accurate since no estimates were provided to respondents.
Behavior Change Intentions.
Behavior change intentions related to CRC screening, mammography screening, physical
activity, and diet, as well as intentions to talk to a doctor about getting tested for CRC, were
assessed at pre- and post-intervention. Based on previous CRC screening research [45],
respondents were asked a single item adapted for each behavior, “How likely are you to [get
screened for colorectal cancer, improve your diet, and increase your physical activity] in the next
6 months?” on a five-point Likert scale “not at all to “extremely.” Participants classified as upto-date on CRC or mammography screening based on their prior responses about screening
history, were asked about screening intentions with an alternative ending, “…when you are due
to screen again?”
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Analyses
Independent samples t-tests were used to test differences between treatment and control
groups in the primary outcome (i.e., post-intervention CRC numeric lifetime risk perception).
Subsequent independent samples t-tests and chi-squared tests of association (for categorical
outcomes) were used to test for differences between intervention groups in secondary outcomes
(i.e., absolute and relative risk perceptions, behavioral intentions, and breast cancer risk
perception at post-intervention). To explore within group differences a series of ad hoc analyses
were performed using paired samples t-tests (for continuous outcomes) and McNemar's tests (for
categorical outcomes) to detect changes within each group (from pre- to post-intervention).
Results
Sample
Approximately 63,500 panelists were sent survey invitations. Among those solicited for
participation, 1,448 panelists clicked on the survey link and consented to participate, including
n=671 ineligible panelists per study criteria and an additional 220 per sample quota criteria (i.e.,
over quotas). Among the remaining 557 respondents, 71 failed to complete the survey (13%) and
an additional 67 were removed for failing an attention check (i.e., they did not provide the
requested response) (12%). A total of n=419 completed surveys were collected from study
eligible participants, resulting in a 24% response rate [46]. Sample characteristics overall and by
intervention arm are provided in Table 2.
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Primary Outcome
CRC Numeric Lifetime Risk Perception.
No significant differences were observed in any of the post-intervention CRC risk
perception measures between the treatment and control groups (Table 3). However, within both
groups, the average numeric lifetime risk reported was significantly reduced at post-test
(compared to pre-test) (t(211) = -5.576, p < .001 and t(206) = -4.848, p < .001 for treatment and
control, respectively) and indicated greater accuracy in lifetime risk (χ2(1) = 87.258, p < .001 and
χ2(1) = 60.800, p < .001, for treatment and control, respectively).
Secondary Outcomes
CRC Absolute and Relative Risk Perceptions.
The single item indicator of absolute risk of CRC was approaching statistical significance
(t(417) = -1.874, p = .06), with higher risk reported in the treatment group, compared to control
(Table 3). Post-hoc tests assessing pre-post change in each group found a significant increase in
absolute risk was observed within the treatment group at post-test, compared to pre-test (t(211) =
2.677, p = .008). Relative risk trended towards a significant decrease within the treatment group
(t(211) = -1.818, p = .07). There were no significant differences in absolute or relative risk
perception within the control group.
Behavior Change Intentions.
Post-test intentions to talk to a doctor about CRC screening and intentions for CRC
screening, diet and physical activity did not differ significantly by study arm (Table 3). However,
behavioral intentions increased for screening, diet, and physical activity among 25-30% of all
participants (data not shown). In post-hoc analyses of pre-post change significant increases in
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intentions to talk to a doctor about CRC screening (t(211) = 3.932, p < .001 and t(206) = 5.148, p
< .001 for treatment and control, respectively) as well as CRC screening intentions (t(211) =
3.961, p < .001 and t(206) = 4.783, p < .001 for treatment and control, respectively) were
identified. Physical activity intentions increased within the control group only (t(206) = 2.175, p
= .031), while diet intentions did not significantly change within either group.
Breast Cancer Risk Perceptions.
There were no significant differences observed in any of the post-intervention breast cancer
risk perception measures between the treatment and control groups (Table 3). There were no
significant differences within groups in absolute or relative perceptions of breast cancer risk,
although a decrease in absolute risk at post-invention was approaching significance within the
control group (t(137) = -1.914, p = .06). Within both the treatment and control groups, the
average numeric lifetime risk of breast cancer reported was significantly lower at post-test
compared to pre-test (t(140) = -2.142, p =.034 and t(137) = -3.111, p = .002, for treatment and
control, respectively); accuracy in numeric lifetime risk of breast cancer, however, did not
change significantly within either group. Post-hoc McNemar’s tests revealed that the overall
proportion of individuals who overestimate their lifetime risk of breast cancer significantly
decreased, while the overall proportion of individuals who underestimate significantly increased
(χ2(1) = 7.902, p < .01 and χ2(1) = 6.919, p < .01, overestimate and underestimate, respectively)
[data not shown].
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Mammography Screening Intentions.
Post-test mammography screening intentions did not differ significantly by intervention arm.
Intentions for mammography screening increased within the control group (t(137) = 2.166, p =
.032). There were no significant changes within the treatment group.
Discussion
Although the hypothesized differences between study arms in post-intervention risk
perceptions and behavioral intentions were not supported, several significant within group
differences were observed. Specifically, perceived numeric lifetime risk of CRC lowered and
seemed to spillover onto female participants’ perceived lifetime risk of breast cancer. Results
also suggest that cancer risk assessment tools may facilitate behavior change intentions,
especially screening intentions. Taken together, findings suggest that risk communication
interventions may not need to provide personalized content to improve accuracy of perceived
numeric lifetime risk and drive screening intentions among those at average risk of CRC.
The null results between groups on risk perceptions and behavioral intentions do not
necessarily contradict the body of literature favoring personalization over non-personalized risk
communication [25, 47]. In this study, it is possible that the personalized component of the risk
results was overshadowed by the lifetime risk estimate provided to participants. That the overall
lifetime risk of participants decreased suggests that the numeric estimate may have been more
salient than the information provided on risk factors (regardless of personalization). Therefore,
future risk communication research targeting those at average should emphasize that average risk
is not zero risk and make messages on the outcomes related to specific lifestyle changes, e.g., the
number of CRC cases or CRC deaths that could be prevented, the central focus of the risk
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feedback. In order to prevent diminished risk perception among those at average risk, risk
communication strategies could also aim to increase awareness of the prevention paradox, the
common scenario in which the majority of cases of a disease occur in those at low or moderate
risk, while only a same percent occur in those at high risk [48].
Numeric lifetime risk of CRC reported at post-intervention was significantly lower than at
pre-intervention in both intervention arms. This reduction reflects greater accuracy in perceived
lifetime risk and adds to the body of literature demonstrating improved risk perception accuracy
after risk assessment feedback [23-24, 27, 38, 49]. Additional research is needed to identify the
cognitive and behavioral implications of altering lifetime risk perception accuracy among
average risk individuals. In particular, future studies should evaluate whether increased risk
perception accuracy among average risk individuals is beneficial or detrimental (i.e., leads to a
false sense of security and impedes adoption of health behaviors).
Women’s’ perceived lifetime risk of breast cancer also significantly decreased at postintervention (compared to pre-intervention), regardless of study arm. These unexpected changes
in women’s perceived lifetime risk of breast cancer following CRC risk feedback may represent
an unintended, and potentially adverse, consequence of providing cancer type-specific
assessment results. Future research is warranted to replicate these results. In the meantime,
cancer prevention and risk communication professionals should be cognizant of the potential for
such spillover effects.
On the other hand, CRC screening intentions as well as intentions to talk to a doctor about
CRC screening significantly increased at post-intervention (compared to pre-intervention), again
regardless of group. This finding suggests that cancer risk assessments may be useful in

43

promoting screening behavioral intentions among average risk individuals regardless of whether
the content is personalized. Within the control group, mammography screening intentions also
increased at post-intervention. This is somewhat surprising given both perceived lifetime and
absolute risk decreased in this group (although the latter did not reach statistical significance).
This result may indicate that generic feedback on specific risk factors (including screening
behavior) is more likely to produce spillover intentions on other types of cancer. Findings such
as these highlight the importance of explicitly test for spillover effects as interventions that can
successfully change multiple behaviors are likely to be more efficient than those targeting one
behaviors at a time.
While results related to screening intentions are encouraging, there were limited effects
observed on diet and physical activity intentions. The null results related to diet intentions is
particularly worrisome given that dietary habits are strongly associated with CRC risk and an
unhealthy diet was the most prevalent risk factor identified in this sample. It is possible that
screening is perceived differently, i.e., a “one and done” behavior to reduce risk, as opposed to
an ongoing, daily change in lifestyle. Alternatively, screening was the only negatively-framed
message; therefore, behavioral intentions of average risk individuals may be influenced more by
negatively-framed prevention messages, although this would contrast prior work supporting an
advantage of gain-framed messages on preventive behaviors intentions [41, 50]. Moreover, the
positive/negative framing of messages only applied to the behaviors regarded as risk factors. The
presence or absence of risk factors (as defined by participant reported engagement in health
behaviors) produced variation within the treatment arm personalized messages. Potential
differences in outcomes associated with the varying message combinations were not evaluated in
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the present study. It is possible that these differences within the treatment arm muddied our
ability to detect the effects of personalization. Future research should examine specific forms of
personalization more closely within defined risk groups. These results underscore the need for
future research on the role risk information plays in promoting behavior change intentions, and
in addition, the relative difficulty researchers face in “moving the needle” on lifestyle
modifications among individuals without a family history of cancer.
Finally, the null findings between trial arms may be partially explained by the average risk
(and thus by definition low risk) status of the study sample. Participants were purposefully
provided with a low numerical risk estimate of less than 5% which may have been judged of
insufficient magnitude to heighten perceptions of risk. This supposition is bolstered by the fact
that perceived numeric lifetime risk of CRC decreased in both groups post-intervention. If this
explanation were true, it would provide a potential caveat to prior research suggesting that
personalized risk feedback is more successful in motivating changes in lifestyle behaviors [51].
However, the single item used to indicate absolute risk significantly increased from pre- to postintervention within the treatment group and was approaching statistical significance (t(417) = 1.874, p = .06), with higher risk reported in the treatment group, compared to control (as
hypothesized). This result offers some evidence pointing to a potentially beneficial role of
personalized information in promoting change (via increased non-numeric perception of risk),
even when provided in combination with average and relatively low estimates of lifetime risk.
Strengths and Limitations
A primary limitation of this study was the relative similarity between the treatment and
control arms. That all participants received a numeric estimate of lifetime risk and information
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on risk factors may explain the limited changes in the primary outcome (i.e., risk perception). It
is also possible that the degree of personalization within the treatment arm was not enough. The
information provided on risk factors could have been further personalized based on participant
age and race/ethnicity. Enhanced personalization that reinforces the threat of CRC (despite being
at average risk), combined with clearer differences between the personalized and nonpersonalized arms, may be necessary to isolate the effects of personalization when
communicating information about risk factors to those at average risk.
In addition, responses from this internet panel sample may not generalize to populations that
do not engage in online research. Nor do survey responses regarding behavioral intent
necessarily translate actual behavioral change. The public use of risk assessment tools may be
influenced by different individual characteristics such as motivations, interests, and readiness to
change. Finally, the lifetime risk estimates provided in this study were based on the average
combined lifetime risk of men and women in the United States and were not personalized for
each respondent. Although the actual estimated range of lifetime risk in an average risk sample
would be relatively small, providing individualized risk estimates may yield different results.
Therefore, it may be beneficial to repeat this study with more precise estimates of lifetime risk.
The limitations of this study are balanced by several strengths. First, the sample is
economically and racially diverse which enhances the ability to generalize findings to such
populations, an uncommon trait of internet samples [52]. In addition, the sample consists of
individuals with average risk for CRC, a relatively understudied, yet critical population to study
cancer risk assessment and preventive behaviors, since the majority of CRC will occur among
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individuals without a family history [53]. Finally, the internet survey did not allow respondents
to skip questions and therefore, there was no need to statistically account for missing data.
Conclusion
Taken together, results here highlight the complexity of cancer risk perceptions and suggest
that cancer risk assessment tools may alter risk perceptions and facilitate behavior change
intentions, especially screening intentions, among an average risk population. Our findings shed
new light on the potential utility of cancer risk assessment tools as vehicles to improve the
accuracy of individuals’ cancer risk perceptions while promoting risk-reducing behaviors.
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Table 1. Treatment Group Messages
Behavior

Protective Message

Risk Message

Screening

You've had one of the colon
cancer screening tests
recently.

Get screened for colon cancer
regularly. If you do not get screened
doctors will not be able to find and
remove precancerous polyps before
they turn into cancer. So, talk to your
doctor about getting screened.
Regular screening is the single best
way to lower your colon cancer risk.

Physical Activity

You are physically active.

Increase your physical activity.
Work towards at least 30 minutes of
physical activity a day. Being
physically active can lower your
colon cancer risk by as much as half.

Diet

You eat a diet high in
vegetables.

Improve your diet. Strive to eat
more vegetables and less than 3
servings of red meat a week. A diet
high in vegetables may help reduce
your risk of colon cancer.
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Table 2. Sample Characteristics Overall and by Intervention Arm (N=419)
Overall
Variable

Control
(n=207)

Demographic Characteristics
Mean Age (sd)
58.5 (6.3)
58.7 (6.3)
Female Gender
279 (66.6)
138 (66.7)
Race
White
140 (33.4)
73 (35.3)
Black
140 (33.4)
64 (30.9)
Hispanic
139 (33.2)
70 (33.8)
Currently Marrieda
203 (48.4)
106 (51.2)
Income
<20k
94 (22.4)
47 (22.7)
20-49k
145 (34.6)
61 (29.5)
50-74k
90 (21.5)
50 (24.2)
75-99k
46 (11.0)
24 (11.6)
≥100k
44 (10.5)
25 (12.1)
College Graduate
203 (48.4)
105 (50.7)
Currently Employedb
173 (41.3)
88 (42.5)
Insured
368 (87.8)
182 (87.9)
Colorectal Cancer Risk Factors/Screening
Mean Targeted Risk Factors/Screening (sd) (0-3)c
1.8 (0.8)
1.8 (0.8)
Colorectal Cancer Screeningd
209 (49.9)
104 (50.2)
Physical Activitye
182 (43.4)
89 (43.0)
Inadequate Vegetable Consumptione
348 (83.1)
176 (85.0)
Note. Values represent total number (column percentage) unless otherwise stated.
a
Currently married or living with significant other
b
Currently employed full-time or part-time
c
Includes CRC screening, physical activity and diet risk factors
d
Not up-to-date per guidelines
e
Inadequate per guidelines
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Treatment
(n=212)
58.3 (6.2)
141 (66.5)
67 (31.6)
76 (35.8)
69 (32.5)
97 (45.8)
47 (22.2)
84 (39.6)
40 (18.9)
22 (10.4)
19 (9.0)
98 (46.2)
85 (40.1)
186 (87.7)
1.7 (0.8)
105 (49.5)
93 (43.9)
172 (81.1)

Table 3. Risk Perceptions and Behavioral Intentions by Group at Pre-Intervention and Post-Intervention (N=419)

Variable
Colorectal Cancer Risk Perceptions
Perceived Lifetime Risk
Mean Percentage (sd) (0-100%)
Accurate Lifetime Risk (N (%))c
Perceived Absolute Risk
Mean Absolute Risk (sd)a
Perceived Relative Risk
Mean Relative Risk (sd)b
Behavioral Intentions
Colorectal Cancer Screening
Mean Screening Intention (sd)e
Mean Intention to Talk to Doctor (sd)e
Physical Activity
Mean Physical Activity Intention (sd)e
Diet
Mean Diet Intention (sd)e
Breast Cancer Risk Perceptions and
Screening Intentions (n=279 women)
Perceived Absolute Risk
Mean Absolute Risk (sd)a
Perceived Relative Risk
Mean Relative Risk (sd)b
Perceived Lifetime Risk
Mean Percentage (sd) (0-100%)
Accurate Lifetime Risk (N (%))d
Mammography Screening
Mean Mammography Intention (sd)e

Control
(n=207)
n (%)

Post-Intervention
Treatment
Between
(n=212)
Groups1,2
n (%)
p

Pre-Intervention
Control
Treatment
(n=207)
(n=212)
n (%)
n (%)

Within Groups3
Control Treatment
p

p

11.0 (16.6)
92 (44.4)

11.0 (16.0)
103 (48.6)

0.999
0.396

18.9 (21.1)
15 (7.2)

17.8 (20.9)
10 (4.7)

0.000
0.000

0.000
0.000

2.2 (0.9)

2.4 (1.0)

0.062

2.1 (0.9)

2.2 (1.0)

0.170

0.008

2.3 (0.9)

2.2 (1.0)

0.378

2.3 (1.0)

2.3 (1.1)

0.93

0.071

3.0 (1.4)
2.9 (1.3)

3.2 (1.5)
2.9 (1.4)

0.278
0.844

2.7 (1.4)
2.6 (1.3)

2.9 (1.4)
2.7 (1.3)

0.000
0.000

0.000
0.000

3.2 (1.1)

3.2 (1.2)

0.867

3.1 (1.2)

3.1 (1.2)

0.031

0.180

3.3 (1.2)

3.3 (1.2)

0.917

3.2 (1.2)

3.2 (1.1)

0.175

0.471

2.4 (1.0)

2.5 (1.0)

0.492

2.5 (1.0)

2.4 (1.1)

0.058

0.154

2.6 (1.1)

2.5 (1.0)

0.474

2.6 (1.0)

2.5 (1.1)

0.433

0.347

22.1 (23.1)
12 (11.2)

20.6 (24.1)
14 (12.2)

0.606
0.824

26.2 (24.4)
15 (14.0)

22.5 (24.0)
15 (13.0)

0.002
0.629

0.034
1.000

3.9 (1.4)

3.8 (1.5)

0.754

3.7 (1.4)

3.7 (1.4)

0.032

0.338
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Note.
1
Between groups: post-test only comparison between treatment vs. control (independent samples t-tests and chi-squared test of association)
2
Analyses controlling for pre-test values were performed and did not produce different outcomes.
3
Within groups: pre-test vs. post-test (paired samples t-tests and McNemar's tests) within each group (control and treatment)
a
Item measured on a 5 point Likert scale, Very Unlikely (1) to Very Likely (5)
b
Item measured on a 5 point Likert scale, Much Lower (1) to Much Higher (5)
c
Between 4-5% coded as accurate
d
Between 10-15% coded as accurate
e
Item measured on a 5 point Likert scale, Not At All (1) to Extremely (5)
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Figure 1. Lifetime Risk for Colorectal Cancer
A

B

Note. Figure 1 depicts lifetime risk for men (A) and women (B).
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Figure 2. Control Group Risk Factory Message
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Figure 3. Treatment Group Risk Factor Messages
A

B

Note. Figure 3 depicts risk factors framed as risk (A) and protective (B) factors.
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Footnotes
1
Qualtrics outsourced recruitment to partner companies with established panels.
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CHAPTER 3
Paper Two
POST RISK ASSESSMENT COLORECTAL CANCER LIFETIME RISK ACCURACY AND
BEHAVIOR CHANGE INTENTIONS
Abstract
Background
Accurately gauging risk may be an important factor in promoting preventive health
behaviors. Cancer risk assessment can improve risk perception accuracy, but little is known
about how improved accuracy affects health behavior change intentions within the average risk
population.
Purpose
The purpose of this study was to examine accuracy of perceived lifetime risk of CRC prior
to and immediately following receipt of CRA feedback within a sample of average risk adults.
We also assessed whether improvement in perceived lifetime risk accuracy was associated with
changes in behavior change intentions for physical activity, diet and attending CRC screening.
Methods
Data were collected as part of a pre-post parallel design randomized controlled trial
examining the impact of CRC cancer risk assessment (CRA) feedback. Adults aged 50-75 years
with no personal or family history of CRC (N=419) were enrolled in the parent study.
Participants’ colorectal cancer risk perceptions and behavioral intentions were ascertained
immediately before and after risk assessment administration.

62

Results
Accuracy of perceived lifetime risk significantly improved after CRA feedback. Those who
were White (compared to Black or Hispanic), married, college educated (compared to college
graduates) and had higher numeracy were more likely to report accurate lifetime risk post-CRA.
No differences in behavioral intentions were reported between those with improved accuracy and
those who remained inaccurate post-CRA.
Conclusion
CRAs can significantly improve perceived lifetime risk accuracy among those at average
risk. Although improved accuracy was not associated with increased behavioral change
intentions, it is reassuring that improved accuracy (via a decrease in perceived risk) did not
inhibit (reduce) intentions for health behaviors.
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Background
Although CRC incidence is relatively low within the U.S. population, it is not a negligible
threat and should not be dismissed. Colorectal cancer (CRC) is the third most commonly
diagnosed cancer among men and women in the United States (US) and the second leading cause
of cancer deaths overall [1]. Approximately 50,000 deaths were estimated to occur from the
disease in 2017 [1]. CRC risk can be reduced through regular screening and lifestyle
modification, such as improving diet and physical activity [2-4]. In fact, it has been estimated
that as much as 70% of CRC cases could be prevented through lifestyle modification and
widespread screening [5]. However, roughly 32 million Americans believe nothing can be done
to reduce an individual’s cancer risk [6]. Informing the public on disease risk and the modifiable
risk factors for CRC may be an important first step in motivating changes in lifestyle and other
risk-reducing behaviors, such as cancer screenings. Numerous theories of health behavior
provide rationale for using risk information to promote cancer prevention, postulating that
increasing an individual’s perception of risk will lead to behavioral changes to reduce risk [7-9].
Cancer risk prediction models and assessment tools, hereafter referred to as cancer risk
assessments (CRAs), have been developed to convey risk information and inform prevention
strategies. Although CRAs are typically used for those at increased risk in the clinical setting,
CRAs have the potential to inform prevention strategies across the spectrum of cancer risk [10].
A systematic review of trials using CRAs in primary care (n=11) suggests potentially beneficial
effects of risk assessment feedback in accuracy of risk perceptions and screening intentions,
without increasing cancer-related anxiety [11]. However, the relatively small evidence base in
this review was heterogeneous in terms of cancer and intervention type and included studies
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targeting groups with existing concerns about their risk due to family history. Within CRC
specifically, population level approaches to risk reduction would yield highest benefits, since
approximately 70% of CRC cases occur in patients with no family history of the disease (i.e.,
“average risk” individuals) [12]. However, little is known about the application of CRAs for
population approaches to cancer prevention (i.e., targeting the whole population, not only those
at high risk), or the psychosocial and behavioral impact of CRA feedback on average risk
individuals, who represent the majority of colorectal cancer cases.
Despite the threat, perceptions of CRC risk are low in the general population [13-15] and
often incorrectly estimated in average risk research samples [16-17]. Accurately gauging risk
may be an important factor in promoting preventive health behaviors within the average risk
population who may not receive as compelling of behavioral recommendations as those
identified as high risk. Previous research has suggested that providing personalized CRC
absolute and relative risk estimates improves the accuracy of these risk perceptions among older
adults with no personal history of cancer [16-17]. Categorical relative risk estimates (e.g.,
“average risk”) and absolute risk estimates (e.g., “x chances in 1000”) over a 20-year period
were provided in these studies. However, an estimate of the accumulated risk over a lifetime may
provide more valuable information to adults with average CRC risk. Specifically, being informed
that your lifetime risk of developing CRC is between 4-5%, may elicit different risk perceptions
and behavior change intentions than other risk presentation formats. It is unclear whether the
provision of CRA results will improve lifetime risk perceptions among individuals with no
personal or family history of CRC and whether improved accuracy of lifetime risk is beneficial
among those at average risk. Moreover, it is not known if improved accuracy of lifetime risk
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increases uptake of preventive health behaviors or alternatively could contribute to ambivalence
or discourage the adoption of lifestyle change behaviors.
The present research study examined individuals’ accuracy of perceived lifetime risk of
CRC prior to and immediately following receipt of CRA feedback within a sample of average
risk adults. The aims of this study were to: characterize perceived lifetime risk prior to CRA
feedback; examine predictors of baseline perceived lifetime risk accuracy and identify predictors
of improved risk perceptions among those who were inaccurate at baseline. A final question
assessed whether improvement in perceived lifetime risk accuracy was associated with changes
in behavior change intentions for physical activity, diet and attending CRC screening.
Methods
Study Design
Data for this study was collected as part of an IRB approved randomized controlled trial
examining the impact of CRA feedback on perceived risk and behavioral intentions using a prepost parallel trial design.1 As part of that parent study the participants were randomized to one of
two arms receiving colorectal cancer risk results including a population-based estimate of
average lifetime risk according to gender (4.7% for men and 4.4% for women) and information
about CRC risk factors that was either invariant and non-personalized (arm one) or personalized
recommendations based on respondent reported risk factors (arm two). No effects for
intervention arm on risk perceptions or behavioral intentions were found in the parent study. For
the purposes of this study, intervention arm was used as a covariate in regression analyses.
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Sample and Survey Administration
The target population for the study was adults, aged 50-75 years, with no personal or family
history of colorectal cancer, or known predisposition or condition (e.g., inflammatory bowel
disease, polyps or a hereditary syndrome such as familial adenomatous polyposis (FAP) or
hereditary nonpolyposis colon cancer (HNPCC), also known as Lynch Syndrome). The sample
was also limited to English-speaking residents of the contiguous United States.
The study was conducted using Qualtrics, a leading online survey research company, in June
2017. Participants were recruited from existing participant panels.2 Panelists were invited to
participate using a double opt-in process. Potential participants received an email invitation
informing them about the study and providing a link to the study consent form and survey. Quota
sampling was used to obtain a sample balanced by race/ethnic identity (White, Black/African
American and Hispanic/Latino/Spanish origin) and representative ranges of annual household
incomes. Participants received the equivalent of approximately $5.00 remuneration for
participation. Survey items measured numeracy, socio-demographic characteristics (e.g., age,
gender, race, education, marital status, and employment status), and baseline health behaviors
(e.g., physical activity, vegetable consumption, and CRC screening), as well as risk perception.
Outcome Measures
Lifetime Risk Accuracy.
Perceived lifetime risk was assessed at pre- and post-CRA with a single item, “On a scale
from 0 to 100 %, how would you rate the probability that you will develop colorectal cancer in
the future?” with an open-response of 0-100%. A dichotomous measure of lifetime risk accuracy
was created that defined ‘accurate’ as a response between four and five percent, according to
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statistics from the American Cancer Society [18]. A binary variable was also created to indicate
those with improved lifetime risk accuracy at post-CRA (i.e., those with an inaccurate perception
at pre-CRA and an accurate perception at post-CRA).
Behavioral Intentions.
Behavior change intentions related to colorectal cancer screening, diet and physical activity
were measured at pre- and post-CRA. Based on previous CRC screening research [19],
respondents were asked a single item adapted for each behavior, “How likely are you to [get
screened for colorectal cancer, improve your diet, and increase your physical activity] in the next
6 months?” with a five-point Likert response scale of “not at all to “extremely.” Participants
classified as up-to-date on screening (per self-reported screening behavior) were asked about
screening intentions using an alternative ending, “…when you are due to screen again?”
Analyses
Paired samples McNemar's tests were used to assess differences in the proportion of
participants with an inaccurate lifetime risk perception at pre- and post-CRA. Adjusted logistic
regression models were estimated to assess (1) predictors of pre-CRA lifetime risk accuracy and
(2) predictors of post-CRA improvement in lifetime risk accuracy among those who were
inaccurate at pre-CRA while controlling for pre-CRA accuracy level (i.e., overestimate or
underestimate). Those with an accurate perception of lifetime risk at pre-CRA were excluded
from the latter regression analysis. Behavioral intentions were assessed between those with
improved lifetime risk accuracy and those who remained inaccurate at post-CRA using five-point
Likert scales. When regarded as continuous outcomes, independent samples t-tests were used to
test for differences in behavioral intentions. Differences in the proportion of participants that
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increased behavioral intentions from pre- to post-CRA were assessed using chi-squared tests of
association. Analyses were performed using SPSS version 24.
Results
Sample Characteristics
Among the 1,606 panelists that initiated participation (i.e., clicked on the survey link and
completed the consent page), 158 declined, 671 did not meet study eligibility criteria and an
additional 220 screened out due to quota sampling. Seventy-one respondents did not complete
the survey and an additional 67 were removed from the study for failing an attention check (i.e.,
one of three survey items that required specific responses). A total of n=419 eligible participants
were included in this analysis.
Participants were 58.5 years old on average (sd=6.3). Sixty-seven percent of the sample
were female (n=279). As designed, the sample included equal proportions of White, Black, and
Hispanic participants (33% each). Almost half of respondents were married (48%) and college
educated (48%). Less than half were employed (41%) and 43% reported an annual household
income of $50,000 or higher. On average, respondents correctly answered 2.4 (sd=1.2) of the
five numeracy questions accurately. Sample characteristics are presented in Table 1.
Pre-CRA Lifetime Risk
The average perceived lifetime risk of CRC reported at baseline (pre-CRA) was 18%
(sd=21.0); responses ranged between 0 and 100%. As shown in Table 2, few participants (n=25)
had an accurate perception of their lifetime risk of CRC. The majority of participants
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overestimated (57%) or underestimated (38%) their lifetime risk prior to receiving CRA
feedback.
Predictors of Pre-CRA Lifetime Risk Accuracy
Results from an adjusted logistic regression indicated that those currently employed were
less likely to report lifetime risk accurately at baseline (see Table 3). No other factors were
associated with baseline lifetime risk accuracy in this model controlling for numeracy and study
arm.
Predictors of Improved Post-CRA Lifetime Risk Accuracy
The overall average perceived lifetime risk reported post-CRA was 11% (sd=16.3);
responses ranged between 0 and 95%. As shown in Table 2, n=195 participants had an accurate
perception of their lifetime risk for colorectal cancer post-CRA (47%). The proportion of
participants with an accurate perception of lifetime risk significantly increased from pre to post
(χ2(1) = 148.755, p < .001). Concurrently, the proportions of participants underestimating and
overestimating their lifetime risk significantly decreased from pre- to post-CRA (χ2(1) = 33.307,
p < .001 and χ2(1) = 73.333, p < .001 for underestimating and overestimating, respectively).
Among the n=394 participants with an inaccurate perception of lifetime risk at pre-CRA,
n=181 improved their perception of lifetime risk from inaccurate to accurate at post-CRA (χ2(1)
= 179.006, p < .001). Table 4 presents results of the logistic regression analysis testing the role of
participant characteristics, controlling for numeracy, pre-CRA accuracy level, and study arm, on
improved accuracy of lifetime risk at post-CRA. Whites (compared to Blacks and Hispanics),
those who were married, those with some college education (compared to college graduates) and
higher numeracy had a higher likelihood of reporting an accurate lifetime risk post-CRA. The
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likelihood of lifetime risk accuracy at post-CRA was not statistically different between those
with a high school degree or less education and those with a college degree.
Post-CRA Improved Lifetime Risk Accuracy and Behavioral Intentions
The behavioral intentions of participants who improved lifetime risk accuracy from pre to
post were not significantly different from those that remained inaccurate at post-CRA. As shown
in Table 5, there were no differences in the mean behavioral intentions for screening, diet and
physical activity at post-CRA between those who improved accuracy and those who remained
inaccurate (left side of table). Similarly, no differences were observed in the proportion of
participants that increased their behavior change intentions for any behavior from pre to post
between those with an improved perception of lifetime risk and those who remained inaccurate at
post-CRA (right side of Table 5).
Discussion
In order to understand who stands to benefit from receiving cancer risk information, this
study identified predictors of CRC perceived lifetime risk accuracy prior to and following CRA
feedback. The analysis of predictors of post-CRA perceived lifetime risk accuracy revealed
higher likelihood of accuracy among Whites (compared to Blacks and Hispanics), the married,
those with some college (compared to college graduates) and higher numeracy. One of the more
interesting findings is that instead of revealing who is most likely to benefit from CRA feedback,
results implied meaningful information about who was less likely to benefit. In particular, we
found lower post-CRA accuracy was more likely among minorities and individuals with low
numeracy. Higher proportions of Blacks and Hispanics continued to underestimate (29% and
24%, respectively, compared to 17% Whites) and overestimate (37% and 34%, respectively,
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compared to 21% Whites) their risk post-CRA. Understanding what is driving the differences
within these traditionally underserved subgroups of the population could help inform the
development of more effective risk communication strategies. Previous research using national
data has observed lower cancer risk perceptions among Blacks and Hispanics compared to
Whites [20-22]. At least one study has speculated that racial differences in awareness of family
history of cancer may account for observed differences in cancer risk perception [21]. However,
our results suggest that racial differences in risk perception persist within a sample consisting
entirely of individuals reporting no known family history of CRC. Risk perceptions may also be
influenced by medical mistrust and different health attitudes and perceptions among minority
groups [23]. The finding that those who had low numeracy scores are less likely to have accurate
lifetime risk perception post-CRA is not surprising since previous research has supported an
association between numeracy and the perception of health risks [24]. Since a basic numeric
proficiency is required to understand cancer risk information [25], our results suggest that
communicating risk information that accommodates varying numeracy levels may be important.
As long as disparities in CRC incidence and mortality persist, greater attention is warranted to
understand whether and how risk perception inaccuracies contribute to these disparities and how
best to address these perceptions. [26].
Results of the analysis of predictors of pre-CRA accuracy indicated that currently employed
individuals were significantly less likely to have perceived lifetime risk accuracy, compared to
those not currently employed. Although this is an unexpected finding it should be interpreted
with caution as only 6% of participants accurately reported lifetime risk of CRC at pre-CRA. A
larger sample size may be necessary to establish a better understanding of baseline predictors of
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lifetime risk accuracy and subsequently, to characterize those who may be most in need of CRA
feedback. Moreover, the proportion of employed adults in this sample is somewhat lower than
the proportion of employed adults in the U.S. population of adults aged 50-75 years (41% versus
53%, respectively) [27]. Future research is needed to determine how generalizable internet
samples are to the population and to other research samples using different sampling strategies,
especially when targeting older adults.
An examination of improvements in lifetime risk perception and behavior change intentions
revealed no differences in intentions between those with an accurate versus inaccurate lifetime
risk perception at post-CRA. It may be that accuracy of lifetime risk perception is not a
significant precursor to the adoption of preventive behaviors or, in this case, it may be that
having accurate knowledge of the average lifetime risk of CRC is not a salient catalyst to
produce health behavior change intentions. Considering that knowledge alone is considered
necessary but not sufficient to change behavior, additional studies should focus on developing
effective messages in the context of CRA to emphasize not only that those at average risk are
still at risk but also to encourage health behavior change to reduce risk and prevent disease. For
example, rather than emphasizing the accuracy of lifetime risk, which at 5% is rather low, public
health messaging can focus on the benefits of prevention and early detection behaviors in terms
of the proportion of cases prevented.
Strengths and Limitations
By exploring whether risk perception accuracy was associated with behavior change
intentions, this study helped fill a gap in the existing literature base. Although improved accuracy
was not associated with positive behavioral intentions as expected, that intentions did not
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decrease when perceived risk lowered provides novel information. Results also point to future
directions for research. The items assessing lifestyle behavioral intentions were possibly phrased
too broadly. Asking specifically about intentions to increase intake of fruits and vegetables or
reduce red meat consumption, for example, may have produced different outcomes than asking
about intentions to “improve your diet.” Another potential limitation of the present research is
that we did not fully capitalize on having a racially/ethnically diverse sample. Providing
culturally-sensitive personalized messages by racial/ethnic group could better promote behavior
change intentions and therefore, should be incorporated in future studies examining CRA
feedback.
Conclusion
Very few participants had an accurate understanding of lifetime risk for CRC at baseline.
Although the percentage of participants with accurate lifetime risk significantly increased
following CRA feedback, more than half of participants remained inaccurate. This demonstrated
lack of awareness of CRC risk is concerning. Minorities and those with low numeracy were more
likely to report inaccurate perceptions post-CRA, highlighting well-documented disparities in
risk perception and the comprehension of complex, numerical information. Although accuracy at
post-CRA was not associated with increased behavioral intentions, it is reassuring that improved
accuracy (often via a decrease in perceived risk) was not associated with lower health behavior
intentions. In conclusion, accuracy of perceived lifetime risk is just one facet of potential
outcomes to examine following CRA. Additional research is needed to improve post-CRA
accuracy and understanding among minority and low numeracy groups, including testing risk
communication strategies conveying risk information tailored to an individual’s race and
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numeracy. Future public health efforts should continue to explore the potential utility of CRAs to
promote cancer prevention in both high and average risk groups.
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Table 1. Sample Characteristics (N=419)
n (%)
Variable
Mean Age (sd)
58.5 (6.3)
Female Gender
279 (66.6)
Race
White
140 (33.4)
Black
140 (33.4)
Hispanic
139 (33.2)
a
Currently Married
203 (48.4)
Income
<20k
94 (22.4)
20-49k
145 (34.6)
50-74k
90 (21.5)
75-99k
46 (11.0)
≥100k
44 (10.5)
College Graduate
203 (48.4)
b
Currently Employed
173 (41.3)
Mean Numeracy (sd) (0-5)
2.4 (1.2)
Note.
a
Currently married or living with significant other
b
Currently employed full-time or part-time
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Table 2. Accuracy Level of Perceived Lifetime Risk of CRC at Pre- and Post-CRA (N=419)
Accuracy Level
Underestimated
Accurately Estimated
Overestimated

Pre-CRA
(n (%))
157 (37.5)
25 (6.0)
237 (56.6)

Post-CRA
(n (%))
98 (23.4)
195 (46.5)
126 (30.0)
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p
<0.001
<0.001
<0.001

Table 3. Adjusted Logistic Regression: Pre-CRA Perceived Lifetime Risk Accuracy (N=419)

Variable
Numeracy
Age (years)
Male Gender (ref: Female)
Race (ref: White)
Black
Hispanic
Married (ref: Not Married)
Education (ref: College
Graduate)
High School Degree or Less
Some College
Employed (ref: Not Employed)
Study Arm (ref: Control)
(Constant)

Pre-CRA Accurate Lifetime Risk Perception
95% CI for
EXP(B)
B
SE B
Wald
df Exp(B) Lower Upper
0.151
0.162
0.864
1 1.163
0.846
1.598
-0.002 0.035
0.004
1 0.998
0.932
1.068
-0.239 0.471
0.258
1 0.787
0.313
1.982
-0.289
-0.001
0.186

0.560
0.525
0.436

0.266
0.000
0.182

1
1
1

0.749
0.999
1.205

0.250
0.357
0.512

2.244
2.797
2.835

-1.146
0.414
-1.557
-0.405
-2.194

0.693
0.490
0.586
0.433
2.281

2.738
0.714
7.066
0.874
0.926

1
1
1
1
1

0.318
1.513
0.211
0.667
0.111

0.082
0.579
0.067
0.285

1.236
3.953
0.664
1.559
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Table 4. Adjusted Logistic Regression: Post-CRA Improved Perceived Lifetime Risk Accuracy
(n=394)

Variable
Numeracy
Age (years)
Male Gender (ref: Female)
Race (ref: White)
Black
Hispanic
Married (ref: Not Married)
Education (ref: College
Graduate)
High School Degree or Less
Some College
Employed (ref: Not Employed)
Pre-CRA Overestimate (ref:
Underestimate)
Study Arm (ref: Control)
(Constant)

B
0.314
-0.009
-0.053

Post-CRA Accurate Lifetime Risk Perception
95% CI for
EXP(B)
SE B
Wald df Exp(B) Lower Upper
0.085
13.671 1
1.369
1.159
1.616
0.019
0.239
1
0.991
0.955
1.028
0.241
0.049
1
0.948
0.591
1.522

-0.970
-0.718
0.545

0.287
0.274
0.226

11.397
6.859
5.814

1
1
1

0.379
0.488
1.724

0.216
0.285
1.107

0.666
0.835
2.685

-0.385
0.586
0.048

0.278
0.299
0.240

1.925
3.850
0.040

1
1
1

0.680
1.797
1.049

0.395
1.001
0.656

1.172
3.227
1.679

0.393
0.231
-0.458

0.234
0.223
1.243

2.825
1.075
0.136

1
1
1

1.481
1.260
0.633

0.937
0.814

2.342
1.950
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Table 5. Behavioral Intentions by Post-CRA Perceived Lifetime Risk Accuracy (n=394)

Behavior
Screening
Diet
Physical
Activity

Mean Intentions (sd)
Improved
Inaccurate
(n=181)
(n=213)
3.22 (1.5)
3.00 (1.5)
3.25 (1.1)
3.33 (1.3)
3.22 (1.1)
3.21 (1.2)

p
0.135
0.512
0.972
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Increased Intentions (n (%))
Improved
Inaccurate
(n=181)
(n=213)
46 (25.4)
69 (32.4)
39 (21.5)
57 (26.8)
42 (23.2)
58 (27.2)

p
0.129
0.230
0.360

Footnotes
1
Detailed study procedures can be found in Paper 1.
2
Qualtrics outsourced recruitment to partner companies with established panels.
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CHAPTER 4
Paper Three
ONLINE PANEL SAMPLE RECRUITMENT AND CHARACTERISTICS: AN ANALYSIS
OF THOSE WHO INITIATE VERSUS COMPLETE AN INTERNET SURVEY
Abstract
Background
Using online research panels can be a quick and efficient means of sample acquisition and
data collection. Despite this strength, there is often a lack of transparency in the recruitment of
panelists and insufficient consideration of how samples derived from online panels compare to
relevant populations and other research samples.
Purpose
The purpose of this study was to inform researchers on what to expect when administering
an online survey and recruiting participants using quota sampling through a commercial research
panel. The sociodemographic characteristics of those who completed the survey were compared
to those who initiated but did not complete it. The survey exit point of non-completers was also
examined.
Methods
A total of N=419 eligible respondents completed an online survey administered via
Qualtrics. In addition to study-specific eligibility criteria, sampling quotas were implemented for
race and income.
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Results
The majority of panelists who provided consent and were eligible for participation went on
to complete the survey. The sociodemographic profiles were similar between survey completers
and eligible respondents who initiated but did not complete the survey. Survey completers were
relatively similar to the U.S. population 50+ years old. Subtle differences were noted in marital
status, income, education, and employment status, but were likely related to the derived sample
being more racially and economically diverse. Other implications for the use of quota sampling,
the placement of key items, and survey length were discussed.
Conclusion
Quota sampling from an online panel can effectively produce a targeted and diverse sample
with reasonable internal and external validity.
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Background
Increased use of online (internet) surveys has led to a rise in commercial survey and market
research platforms. Companies such as Qualtrics (www.qualtrics.com), Survey Monkey
(www.surveymonkey.com), and Amazon’s Mechanical Turk (MTurk; www.mturk.com) allow
researchers to develop, test, and distribute surveys online. In addition to creating electronic
surveys for distribution through typical sample outlets, these companies enable researchers to
purchase access to existing pools of potential participants that have agreed to be solicited for
survey recruitment. Utilizing online research panels for sample acquisition and data collection is
quick and efficient. Compared to traditional survey modes (e.g., mail and telephone), online
surveys are typically less expensive [1] and growing evidence suggests that samples recruited
through online panels can be as representative of the population as traditional recruitment
methods [2-4].
Online research panels can be particularly effective in targeting specific groups, such as
respondents who meet a specific condition of interest to the researcher. The use of quota
sampling (i.e., a non-probability sampling technique) in online panel research can help
researchers obtain survey participants matching specified criteria, such as employed adults or
young women aged 18-24 years. Although these are clear advantages, concerns about validity of
commercially derived online panel samples have been raised [5-7].
Potential threats to validity come from a variety of sources. Online panel members are
recruited from a variety of sources [2] and therefore, precise information on how sampling
frames are constructed is usually not available. Selection bias may threaten the external validity
of online panels if, for example, panel participants are substantively different than the population
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of interest. In addition, racial minorities, older adults, and those with lower levels of educational
attainment and income are less likely to have broadband internet service [8]. Although lower
income populations may have internet access through a smartphone [9], prior research has shown
few panel respondents use smartphones to complete online surveys accessible through multiple
platforms (e.g., PC, laptop, tablet, and smartphone) [10]. Online panel samples are also subject to
panel bias whereby panelists’ responses may change based on their participation in the panel
[11]. Because of these potential drawbacks and the relative lack of control researchers have over
sample acquisition procedures, a characterization of who panel participants are, how they are
recruited, and whether there are differences in those who complete and do not complete an online
survey is needed to inform researchers on the validity of online sample panels.
To better understand the treats to validity of these panels, we describe the recruitment and
sampling process of an internet-based survey and evaluate the sociodemographic characteristics
of the online sample. The specific aims of this study are as follows: (1) to describe the
recruitment and participant flow of a survey administered by a commercial research platform
using quota sampling; (2) to describe the sociodemographic characteristics of eligible
respondents that complete the survey and respondents that initiate, but do not complete the
survey; (3) to compare sociodemographic profiles of survey completers to respondents who
initiate, but do not complete the survey; and (4) to determine when study-eligible non-completers
exit the survey.
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Methods
Study Design
The current study followed the pre-post parallel trial design of a previously described study
that manipulated the type of information on risk factors (personalized versus generic) for
colorectal cancer survey respondents received in addition to average risk estimates.1 The data
reported in this study were collected according to the IRB-approved protocol. The survey
contained 133 items with each item requiring a response. Completed survey duration ranged
from 10 to 1,922 minutes, with a median duration of 26 minutes. Data collection occurred over a
period of 12 days in June 2017 via an internet survey administered by Qualtrics.
Sample and Survey Administration
Qualtrics recruited the sample from existing pools of research panel participants.2
Recruitment targeted potential survey respondents who were likely to qualify based on the
demographic characteristics reported in their user profiles (e.g., race and age). Panelists were
sent an email invitation with a unique survey link to the study consent form and survey
instrument. To be eligible to participate, respondents had to report being between the ages of 50
and 75 years; no personal or family history of colorectal cancer or other predisposing condition;
reading and comprehending English; and residing in the contiguous United States (U.S.).
Sampling quotas were implemented for race and annual household income. Specifically, a
balanced proportion of respondents with non-Hispanic White, non-Hispanic Black/African

1

Detailed study procedures can be found in Paper 1.

2

Qualtrics outsourced recruitment to partner companies with established panels.
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American, and Hispanic/Latino/Spanish origin racial/ethnic identities and diversity in reported
household income (approximately 20% less than 20k, 30% between 20-49k, 20% between 5074k, 10% between 75-99k = 10% and 20% greater than or equal to 100k) were requested.
Respondents identifying as some other race, ethnicity or origin were not eligible to participate.
Ineligible respondents were immediately exited from the survey upon providing a response that
did not meet inclusion criteria or exceeded set quotas (i.e., a priori quotas for race or household
income group already met). We also removed participants from the sample if they responded
incorrectly to any of three “attention checks” included in the survey (i.e., items that instructed
respondents to provide a specific response).
Results
Recruitment and Participant Flow
Survey recruitment and participant flow is depicted in Figure 1. The survey was distributed
to approximately 63,500 panelists based on target demographics, from which 3,178 interacted
with the survey (i.e., clicked on the survey invitation and/or survey link). Among those who
interacted with the survey, 1,606 completed the consent page. Of these panelists, 158 did not
consent (10%), 671 did not meet eligibility criteria (42%), the majority of whom were ineligible
due to health history (n=574 reported a history of colorectal cancer or other predisposing
condition). Another 220 respondents screened out due to being over quota (14%). Seventy-one
respondents did not complete the survey entirely (4%) and an additional 67 were removed from
the study for failing an attention check (i.e., one of three survey items that required specific
responses) (4%). A total of n=419 eligible panelists completed the survey (26% of those who
completed the consent page).
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A priori income quotas proposed for this study were not fully implemented. Due to
difficulties acquiring participants who reported an annual household income of ≥100k, we
elected to eliminate the income quota after two weeks of data collection. To ensure acquiring the
overall sample size required to meet a priori determined criteria for statistical power for the
parent study (i.e., n=400), we used natural probability sampling to obtain the remaining number
of participants. Ultimately, the final sample consisted of 11% of respondents with ≥100k
reported income instead of the 20% initially proposed.
Sample Characteristics
As shown in Table 1, the average age of the n=419 respondents who completed the survey
was 58.5 years (sd=6.3). The sample consisted of n=279 females (67%) and as intended, an equal
proportion of White, Black, and Hispanic respondents (33% each). Approximately one half of
those completing the survey was married (48%), and an equal proportion was college educated
(48%). Slightly less than half were employed full or part time (41%). Similarly, slightly less than
half reported an annual household income of $50,000 or higher (43%).
In addition to survey completers, Table 1 provides the available sociodemographic
characteristics for the four types of respondents who consented but did not complete the survey
(i.e., survey non-completers). Non-completers are categorized as: (1) incomplete due to drop out;
(2) quality fail (i.e., failed one or more attention check); (3) over quota; and (4) ineligible (i.e.,
did not meet study inclusion criteria related to health history, race, and age). There was a
variable amount of missing data within the non-completer groups as presented in Table 1,
depending on when the respondent exited the survey. For example, a respondent over quota due
to race/ethnicity (item 4) was missing data for age (item 5) and all items thereafter, while a
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respondent quota due to income (item 10) had complete data for all variables described in Table
1.
Additional sample characteristics available on survey completers are presented overall and
by racial/ethnic group in Table 2. Black respondents had lower numeracy scores on average and
were less likely to be married (34%) relative to White and Hispanic respondents (53-59%).
White respondents reported higher income levels and education attainment than minority groups.
Hispanics had a higher proportion of currently employed respondents (47%) than the other
groups (37-40%).
Comparisons of Completers and Non-Completers
Age.
Qualtrics was able to recruit panelists within the targeted age range reasonably well. Ages
within the overall sample ranged from 50-75 years; however, more than half were between 50-60
years old (65%). Only 4% were 71 years and older. The average age of respondents was similar
across all groups, ranging from 57 to 62 years. As shown in Figure 1, only n=24 respondents did
not meet inclusion criteria for age. Among study-eligible respondent groups (i.e., complete,
incomplete, and quality fail), a one-way ANOVA revealed no significant differences in age (F=2,
550)=1.804, p=0.166.
Gender.
Natural probability sampling resulted in more female respondents than males. The
proportion of female respondents was consistently high and similar across all respondent groups,
ranging from 66% to 72% female. Among eligible respondents, a chi-square test of
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independence was conducted and found no differences in gender by completion status
(X2(2)=2.005, p=0.367).
Race.
Because the proportion of White, Black, and Hispanic respondents who completed the
survey was determined by set quotas, we did not compare this group to others on this criterion. A
chi-square test of independence between racial group and the two eligible non-completer groups
(i.e., incomplete and quality fail), however, found no statistically significant associations
(X2(2)=2.272, p=0.321).
The proportion of White respondents was markedly higher in the over quota group relative
to other groups (92% versus 20-35%, respectively). This difference results from the use of
sampling quotas for race and suggests that the quota for White respondents was met before the
quotas for Black and Hispanic respondents.
Income.
Quota sampling was also used to influence the dispersion of reported incomes for survey
completers. Therefore, it would not be appropriate to compare completers to non-completers on
income. However, a one-way ANOVA was performed between the incomplete and quality fail
groups and revealed no statistically significant differences in income, (F=1, 121)=0.637,
p=0.426. There was insufficient data available to describe the ineligible non-completers.
Non-Completer Survey Exit Points
A summary of when study-eligible survey non-completers (i.e., incomplete and quality fail)
exited the survey is presented in Table 3. As shown on the top, 21% of the non-completer group
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did not progress beyond the initial survey screener items (i.e., “early drop outs”). An additional
59% of the non-completers dropped out during the first half of the survey (prior to receiving risk
assessment feedback). These results may indicate the survey was too long to retain interest and
engagement for some participants. The remaining 20% of non-completers exited after
completing more than half of the survey.
Table 3 also shows a breakdown of the specific items within the screening and pre-test risk
perception/health behavior sections, the top areas where incomplete survey respondents exited,
which accounted for a combined 58% of the total group. Within the screening section, most
stopped completing the survey during health history items. Among those who exited within the
pre-test risk perception/health behavior section, respondents were most likely to exit from an
item assessing risk perceptions.
Within the quality fail group (see bottom half of Table 3), comprised of study-eligible
respondents who failed one of the three attention items, approximately one-quarter failed the first
item (28%) and one-quarter failed the second item (22%). Nearly one-half failed the third
attention check (49%).
Discussion
This study informs researchers on what to expect when administering an online survey and
recruiting participants through a commercial research panel. A thorough description of how
quota sampling was used to obtain a racially and economically diverse sample of older adults in
a relatively short period of time was provided. Sociodemographic characteristics overall, as well
as within and between respondent groups, were examined and provided several indicators of
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reasonable sample internal validity. Results provide context and suggestions for future
researchers contemplating the use of commercially administered research surveys.
The level of transparency regarding recruitment and participant flow reported in this study
(e.g., # emailed, # interacting with the survey, analysis of over quota exclusions, etc.) is greater
than that typically reported in other recent studies using online research panels [12-13]. The
information outlined indicates that commercial research platforms have access to large panels of
research participants. Although more than 60,000 panelists were sent a survey invitation, half of
those who interacted with the email ultimately completed the consent page of the survey. Among
those who consented and were eligible for participation, most completed the survey (75%). For
internet derived samples, this ‘completion rate’ (i.e., the proportion of survey completers out of
all eligible respondents who initiate the survey) is more meaningful than a traditional response
rate as unique factors influence panel response that may not be quantifiable by researchers (e.g.,
inactive panel members and invalid emails) [14]. Health history was the primary reason for
ineligibility – a study-specific inclusion criterion. Collectively, these findings indicate that
despite contacting higher numbers of potential participants relative to traditional methods, online
sampling can target participants based on specific age and race parameters well.
The sociodemographic characteristics of survey completers were consistent with the study
inclusion criteria and set quotas (except for the highest income level). Study-eligible respondent
groups were similar in age and gender and no significant differences were identified in race and
income between study-eligible respondent groups that did not complete the survey, which
provides credence for the validity of online panel samples. Furthermore, survey completers
overall were similar to the U.S. adult population aged 50 years and older, though somewhat less
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likely to be married (48% vs. 60%) and to report a household income of $50,000 or higher (43%
vs. 55%) and more likely to possess a college degree (48% vs. 27%) [15]. The resulting sample
was also higher in unemployment (59% vs. 47%) compared to nationally representative data
[16]. These subtle differences in our sample, i.e., lower household income and higher
unemployment, may in part explain the challenge faced in filling the ≥100k income quota.
The proportion of females, often overrepresented in research samples, was somewhat higher
among survey completers in this study (67%) compared to that observed in traditional and other
online samples within the sample topic area [17-20]. Since other studies have produced more
balanced gender proportions without implementing quotas, stratification or quota sampling may
be useful but not necessarily required unless the research dictates an equal gender distribution.
Another suggestion can be gleaned from the examination of exit points of the study-eligible
respondent groups that did not complete the survey. That more three-quarters of the noncompleters exited before the survey halfway point and nearly one-half of the quality fail group
failed the final attention check suggests that participants may have lost interest and paid less
attention towards the end of the survey. This finding is consistent with best practice guidance to
keep surveys – whether traditional or online – as short as possible to increase respondent
retention and attentiveness [21-22].
The placement of demographic items is often debated with some recommending that
demographic items, such as income and age, not be asked at the beginning of a survey [23-24].
Within this study, all respondents in the non-completer group provided income and only one
exited on the age item. Instead, most non-completers exiting within the screening section did so
while answering health history items. This result suggests that panel samples may be more
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accustomed to and/or comfortable with answering demographic questions than traditional
research samples, but may be, nonetheless, sensitive to responding to health-related questions.
It should also be noted that the median survey duration of the non-completer group was over
10,000 minutes (data not shown), substantially higher than the median duration of 26 minutes
among those who completed the survey. Qualtrics panelists have the freedom to “walk away”
from the survey (e.g. leave survey to answer the door or make dinner). The survey will remain
open and incomplete until the respondent returns to complete it or the data collection closes to
the study. Because Qualtrics provides transparency on the total survey duration, researchers may
consider either excluding responses with excessive duration or removing respondents from the
survey after a specified period of inactivity.
Finally, the present study highlights the relative ease of obtaining a racially and
economically diverse sample via quota sampling and online recruitment methods. This represents
a major advantage over traditional sampling methods that often consist of predominantly White
participants [17-19]. Researchers who seek diverse samples should utilize available
representative samples whenever possible. When access to minorities is limited, however, online
panel sampling using quotas sampling for race may be a valuable approach for reaching minority
participants, as demonstrated in this and other panel samples [20, 25].
Strengths and Limitations
This study added transparency to the process of quota sampling and recruiting from an
online research panel and provided novel information to researchers about how best to
implement future research using these methods. There are, however, a few important study
limitations that must be taken into account when interpreting study results. We were unable to
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characterize panelists who did not interact with the email invitation. Although this was a large
number of individuals, there are likely a variety of reasons for this such as inactive or busy
panelists and undeliverable email addresses. Nonetheless, this is an important design factor for
future studies wishing to use online panels. The present study was also unable to describe
panelists who did not consent for participation. Additional research is needed to explore
nonresponse bias in those who do not interact with the survey invitations and decline
participation. Among those who consented for participation, relatively few sample characteristics
could be compared across respondent groups. For example, marital status could not be assessed
across all groups as a result of the order of survey items (e.g., the item assessing marital status
was at the end of the survey, after many non-completers had exited the survey). Within the
present study, ineligible and over quota respondents were exited from the survey immediately
after providing a response that did not meet inclusion criteria or exceeded set quotas. In an effort
to address non-response bias and incomplete descriptive characteristics, researchers should
purposely include relevant items (e.g., marital status and education) at the beginning of surveys
and ask all participants these items, prior to exiting ineligible and over quota respondents from
the survey. Future research should also extend the present study by examining psychological and
behavioral characteristics of online survey respondent groups.
Conclusion
As the use of online surveys and panel sampling increases, researchers must be cognizant of
the strengths and potential pitfalls of using online panels and sampling techniques. Online panel
sampling allows researchers to effectively choose study inclusion criteria and implement quotas
to obtain racially diverse samples in a shorter period of time than traditional sampling methods.
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However, researchers must carefully develop quotas to ensure internal and external validity of
the resulting sample. Although higher numbers of potential participants are contacted in online
panel sampling, our results suggest that among study-eligible respondents, sociodemographic
profiles were similar between survey completers and eligible respondents who initiated but did
not complete the survey. This study produced insights into which sample characteristics
researchers may want to influence with quota sampling.
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Figure 1. Diagram of Recruitment and Participation

63,500 Panelists emailed

3,178 Panelists interacted with survey

1,606 Panelists completed consent page

Consent
Declined to participate (n=158)
 Clicked “I do NOT consent”

Consented to participate (n=1,448)
 Clicked “I consent”

Eligibility
Excluded (n=891)
 Did not meet inclusion criteria (n=671)
− Health history (n=574)
− Race (n=73)
− Age (n=24)
 Over quota (n=220)

Eligible for participation (n=557)

Participation
Did not complete survey (n=138)
 Failed attention check (n=67)
 Incomplete response (n=71)

Completed Survey (n=419)
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Table 1. Respondent Characteristics (n (%))
Eligible Respondents
Ineligible Respondents
Completers
Non-Completers
Complete
Incomplete Quality Fail Over Quota
Ineligible
(N=419)
(n=71)
(n=67)
(n=220)
(n=671)

Sociodemographic Variables
Per Eligibility Criteria
Mean Age (sd)
58.5 (6.3)
57.1 (5.8)
57.6 (6.4)
61.5 (7.2)
Missing
0
4 (1.0)
0
128 (58.2)
Per Quota Sampling
Race
White
140 (33.4)
14 (19.7)
16 (23.9)
202 (91.8)
Black
140 (33.4)
37 (52.1)
28 (41.8)
12 (5.5)
Hispanic
139 (33.2)
17 (23.9)
23 (34.3)
4 (1.8)
Other
n/a
n/a
n/a
n/a
Missing
0
3 (4.2)
0
2 (0.9)
Income
<20k
94 (22.4)
18 (25.4)
25 (37.3)
19 (8.6)
20-49k
145 (34.6)
21 (29.6)
26 (38.8)
41 (18.6)
50-74k
90 (21.5)
10 (14.1)
9 (13.4)
18 (8.2)
75-99k
46 (11.0)
2 (2.8)
3 (4.5)
6 (2.7)
≥100k
44 (10.5)
5 (7.0)
4 (6.0)
2 (0.9)
Missing
0
15 (21.1)
0
134 (60.9)
Natural Probability
Gender
Female
279 (66.6)
51 (71.8)
44 (65.7)
156 (70.9)
Male
140 (33.4)
17 (23.9)
23 (34.3)
62 (28.2)
Missing
0
3 (4.2)
0
2 (0.9)
Note. Values may not equal total sample size or 100% due to rounding and missing data.
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58.7 (8.3)
73 (10.9)

235 (35.0)
185 (27.6)
178 (26.5)
73 (10.9)
0
no data
no data
no data
no data
no data
no data

440 (65.6)
231 (34.4)
0

Table 2. Survey Completer Characteristics by Race/Ethnic Group (n (%))
Overall
(N=419)

White
(n=71)

Black
(n=67)

Hispanic
(n=220)

Variable
Sociodemographic
Mean Age (sd)
58.5 (6.3)
60.1 (6.6)
58.5 (5.9)
57.0 (6.0)
Female Gender
279 (66.6)
89 (63.6)
95 (67.9)
95 (68.3)
a
Currently Married
203 (48.4)
82 (58.6)
48 (34.3)
73 (52.5)
Income
<20k
94 (22.4)
25 (17.9)
36 (25.7)
33 (23.7)
20-49k
145 (34.6)
42 (30.0)
57 (40.7)
46 (33.1)
50-74k
90 (21.5)
24 (17.1)
33 (23.6)
33 (23.7)
75-99k
46 (11.0)
25 (17.9)
8 (5.7)
13 (9.4)
≥100k
44 (10.5)
24 (17.1)
6 (4.3)
14 (10.1)
College Graduate
203 (48.4)
78 (55.7)
58 (41.4)
67 (48.2)
b
Currently Employed
173 (41.3)
56 (40.0)
52 (37.1)
65 (46.8)
Insured
368 (87.8)
128 (91.4)
124 (88.6)
116 (83.5)
English Languagec
400 (95.5)
139 (99.3)
140 (100.0)
121 (87.1)
Other
Mean Numeracy (sd)d
1.0 (0.9)
1.3 (1.0)
0.6 (0.8)
1.0 (0.9)
Mean Health Status (sd)e
3.2 (0.9)
3.3 (1.0)
3.0 (0.8)
3.2 (0.9)
f
Mean Health Literacy (sd)
4.5 (0.8)
4.5 (0.8)
4.6 (0.7)
4.5 (0.7)
Note.
a
Currently married or living with significant other
b
Currently employed full-time or part-time
c
English is primary language spoken at home
d
Assessed using 3-item scale developed by Schwartz and colleagues [26]
e
Assessed on a 5 point Likert scale, with answers ranging from Poor (1) to Excellent (5)
f
Assessed on a 5 point Likert scale, with answers ranging from Not At All (1) to Extremely (5)
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Table 3. Study-Eligible Non-Completer Survey Exit Points
Survey Section
Incomplete Group (n=71)
Screening
Did not start survey
Gender
Race
Age
Colon health history
Breast health history
Income
Risk Perceptions and Health
Behaviors (pre-test)
Did not start section
Risk perceptions
Health behaviors
Numeracy
Lifestyle Behaviors
Survey Halfway Point
Risk Assessment Feedback
Risk Perceptions and Health
Behaviors (post-test)
Demographics
Satisfaction

Item Numbers

Respondents Exited (n (%))

1-10

11-41

15 (21.1)
3 (20.0)
0 (0.0)
0 (0.0)
1 (6.7)
8 (53.3)
3 (20.0)
0 (0.0)
26 (36.6)

42-48
49-69

8 (30.8)
13 (50.0)
5 (19.2)
12 (16.9)
4 (5.6)

70-90
91-114

2 (2.8)
11 (15.5)

115-128
129-133

1 (1.4)
0 (0.0)

Quality Fail Group (n=67)
First Attention Item
33
19 (28.4)
Second Attention Item
64
15 (22.4)
Third Attention Item
108
33 (49.3)
Note. Values may not equal total 100% due to rounding.
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CHAPTER 5
Conclusion
Summary
CRC is the second leading cause of cancer-related mortality in the U.S., accounting for
approximately 50,000 deaths annually [1]. Although the average lifetime risk of CRC is
relatively low, the majority of CRC cases occur among those at average risk - with no personal
or family history of the disease [2]. Therefore, it is imperative that those at average risk perceive
CRC as a formidable threat and take actions to prevent the disease. The present study was
conducted to assess whether providing personalized CRC risk assessment feedback including
behavior change messages would alter risk perceptions and drive risk-reducing behavioral
intentions among those at average risk and age-eligible for screening.
Through a series of related papers, this dissertation evaluated the impact of CRC risk
assessment feedback. The first paper evaluated the effects of providing personalized (vs. generic)
risk assessment feedback on individuals’ risk perceptions and intentions to engage in three riskreducing behaviors. This paper also answered a novel question of whether the provision of CRC
risk information alters perceptions and intentions of a different cancer, breast cancer, which also
has strong lifestyle based risks and population based screening programs. The second paper
examined individuals’ accuracy of perceived lifetime risk of CRC and assessed whether
improved accuracy was associated with behavior change intentions following risk assessment
feedback. Finally, the third paper described and evaluated the sampling procedures and survey
respondent groups of this research. Overall, several significant findings emerged from these three
papers.
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Results provided support for the potential role cancer risk assessments may play in
promoting cancer screening behaviors. That colorectal cancer screening intentions increased
after receiving risk assessment feedback is particularly remarkable within this average risk
sample given that: (1) as average risk, having reported no history of CRC, participants were
provided with a low estimate of lifetime risk (less than 5%); and (2) only half of the sample was
currently up-to-date according to current screening guidelines and this group can be hard to
influence as they report more perceived barriers to screening than those who have had a recent
screening test [2]. Finally, this finding is noteworthy because (3) it suggests that personalized
risk assessment feedback, which may be more time and resource intensive, was not necessary to
produce significant increases in screening intentions since changes occurred in both intervention
arms.
While improving screening intentions is a positive outcome, it should be emphasized that
intentions related to diet and physical activity improvement were not similarly impacted. One
plausible explanation underlying this outcome is that screening may be perceived as a “one and
done” behavior to reduce CRC risk, while changes in diet and physical activity inherently require
ongoing lifestyle modification. Common barriers to screening include knowledge gaps and
structural barriers [3], which can be overcome with narrowly-focused interventions, whereas
lifestyle changes require more complex interventions, providing support and strategies to
improve skills and motivation for ongoing change to daily routines and behaviors [4-5].
Therefore, it may be that those with lifestyle risk factors would indicate intentions to screening
simply because it is the “easier” opportunity to mitigate one’s cancer risk.
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It should also be acknowledged that increased intervention dosage (i.e., repeated exposures
to messages) is often necessary to increase desired effects [6]. While low intensity interventions,
such as patient and provider reminders, have produced favorable changes in CRC screening
behaviors [7-8], the single message “dose” provided in this study may have been insufficient to
produce changes in intent for the behaviors requiring continuous changes. A systematic review
of dietary and physical activity interventions supports this suspicion; with results indicating
effectiveness was associated with increased intervention intensity (e.g., number of sessions,
frequency of contacts, etc.) and the use of specific behavior change techniques [9].
A third possible explanation for the lack of changes in diet and physical activity intentions is
that the conceptual pathway underlying the expected outcome was not supported. Specifically, it
was hypothesized that the provision of personalized risk information would increase risk
perceptions and subsequently, promote higher behavioral changes intentions to mitigate
heightened perceptions of risk. Instead of producing increased risk perceptions as hypothesized,
perceived lifetime risk of CRC lowered within both arms. This outcome is not entirely surprising
given that the sample was comprised of average risk individuals and because people tend to
regard their own risk optimistically and will reduce perceptions of their own risk to maintain the
belief that their risk is lower than average [10-11].
The reduction in perceived lifetime risk reflected improved accuracy following risk
assessment, a finding consistent with prior studies [12-15]. This dissertation built upon this
foundation by characterizing who benefited from improved accuracy and assessing if
improvement in lifetime risk accuracy (at follow up) was associated with changes in behavioral
intentions. Our findings revealed there was significantly less improvement in accuracy among
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Blacks and Hispanics (compared to Whites) and individuals with low numeracy. This result
suggests that different risk communication strategies may be needed for groups who are
traditionally disadvantaged in the healthcare area. Prior research has shown that interventions are
more effective when they are culturally appropriate including, for example, language- and
race/ethnicity-concordant counselors, messages, and materials [17-20]. Therefore, the accuracy
of minority respondents conceivably could have been improved if the present study provided
tailored messages based on known cultural factors (e.g., religiosity, racial identity/pride, family
context) [18-19, 21-22]. This adds to the body of literature promoting cultural relevance in health
interventions targeting racial/ethnic minorities and extends message tailoring guidance to
researchers working with diverse samples. Future research should attempt to tease out the
different pathways underlying differences in risk perception accuracy in different racial/ethnic
and numeracy groups.
Although negative outcomes have been linked to inaccurate risk perceptions and accuracy is
generally regarded as inherently positive [11], the current body of research has not thoroughly
explored how risk perception accuracy is related to health outcomes [13-16]. We found no
association between perceived lifetime risk accuracy and behavior change intentions for any of
the three behavioral outcomes measured. This null result is noteworthy because accuracy was
achieved through a decrease in perceived risk and thus, conceivably could have had a detrimental
impact. Within this study in which roughly one quarter of participants reported increased
intentions to perform risk-reducing behaviors, improved accuracy via a decreased perception of
risk appears to have neither promoted nor inhibited intentions to adopt health behaviors. These
results underscore the need for qualitative research to better understand how risk perceptions and
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behavioral intentions are influenced within the context of risk assessment among those at
average risk.
The sample recruited in this research was purposely racially and economically diverse
because there are known differences in CRC outcomes, screening behaviors, and risk perceptions
by race and socioeconomic status [23-28]. Since samples acquired through traditional means
often consist of mostly White participants [29-31], the current study intentionally enrolled overrepresented minority groups in order to garner broad perspectives on cancer risk assessment
feedback. Future research is planned to examine whether known differences in racial/ethnic
groups are present within this dataset. However, the sociodemographic characteristics of this
diverse sample of older adults were compared and several indicators of reasonable sample
internal validity and external generalizability were found, including limited differences between
respondent groups and between respondents who completed the survey and the U.S. population
aged 50 years and older. Taken together, this study provided support for using quota sampling of
an online panel to acquire a targeted and diverse sample that may have otherwise been difficult
to recruit in a relatively short period of time.
Finally, perhaps the most intriguing finding of this dissertation was that risk assessment
feedback for a specific cancer type produced ‘spillover effects’ on another cancer type. While no
information was provided related to breast cancer, female participants’ perceived lifetime risk of
breast cancer lowered and mammography screening intentions increased among those provided
generic risk information. This finding suggests that generic feedback may be more likely to
produce spillover effects. Prior research has also indicated that not only is cancer screening
uptake correlated with the use of other preventative screenings, but that past uptake of either
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breast or cervical cancer screening directly influences the uptake of screening for the other
cancer [32]. Furthermore, psychological theory (e.g., cognitive dissonance and the theory of selfperception) offers potential insights on spillover effects, stating that people tend to think and act
in consistent ways [33-34]. Therefore, it is conceivable that an intervention that prompts
increased screening intentions for one cancer type would amplify screening intentions for
another cancer type, and would similarly produce a consistent impact on cancer risk perceptions.
Cancer prevention and risk communication professionals should be cognizant of the potentially
positive or negative public health implications of unintended consequences resulting from risk
assessment feedback. In order to leverage spillover effects in such a way that intensifies the
magnitude of cancer prevention efforts, future research is warranted to understand whether and
under what conditions positive and negative spillover effects occur. Focusing on both CRC and
breast cancer screening behaviors may be particularly beneficial, as these two cancers combined
account for nearly 40 percent of all cancers in women [1]. This result, while preliminary, may
indicate that generic feedback on risk factors (including screening) is more likely to produce
spillover screening intentions on another cancer screening type.
Strengths and Limitations
The primary strength of this dissertation is the focus on an average risk population of adults.
This group is largely understudied in risk communication research despite being the population
in which most CRC cases occur. Future research should target this group and aim to uncover
new ways to promote their interest in adopting risk-reducing lifestyles and behaviors. A second
strength related to the sample is that it was both racially and economically diverse, a major
advantage over much of the literature base that is comprised of predominately White sample.
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However it should be noted that the sample heterogeneity may have played a role in the null
results observed. As previously mentioned, the present study was potentially limited in that we
did not address the sample diversity in our personalized messages and because there was
variation in the personalization of risk messages provided in the treatment arm (depending on
participant reported engagement in behaviors). Nonetheless, that this dissertation included an
emphasis on minority participation and focused on nuances of research methods that are
commonly overlooked in the literature (e.g., quota sampling and recruitment from online
research panels) represents a strength over other studies.
Before providing final conclusions, it is important to acknowledge a few limitations of this
research. The main limitation of this dissertation is that the numeric estimates of lifetime risk
provided to participants were the average lifetime risk of CRC according to gender in the U.S.,
and as such, were not fully personalized based on each individuals’ reported risk factors. As
average risk, these estimates would not have change substantially for most. None the less the
impact of providing person-specific lifetime risk estimates is not known.
Another chief limitation of this study is related to how accuracy of lifetime risk perception
was defined. Defined as between four and five percent [35], the range for accuracy was relatively
narrow. A wider approximate for accuracy (e.g., +/– 5%) may have changed the results and
implications of this research. In addition, awareness of personal risk factors putting oneself at
higher than average risk (e.g., eating large amounts of red and process meats or drinking heavily)
may have influenced respondent reports of lifetime risk and artificially reduced the number of
participants considered having an accurate perception. It should also be considered that it may
not be that one’s actual perception of their lifetime risk changed per se as their ability to recall
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the information changed their response to the question. It was not assessed if participants
believed the risk estimate information they were given. Further, it is not known if improved
accuracy remained stable over time. Longitudinal or additional follow-up assessment of accuracy
is needed to detect changes in accuracy and to examine what, if any, association these changes
would have with intention for behavior change.
Another important limitation of this dissertation is that assessment of behaviors was outside
the scope of the study. While behavioral intentions were used as proxy and previous research
supports an association between intentions and completed colorectal cancer screening [36-37], it
should be acknowledged that intentions do not always translate to actual changes in behavior.
Finally, it was not possible to examine some of the characteristics of different respondent groups
due to low or missing data. In order to better assess non-response bias, future research should
ensure that variables of interest are asked to all respondents to the extent possible.
Conclusion
Communicating CRC risk information to average risk adults increased CRC-specific
perceived lifetime risk accuracy and screening intentions. Breast cancer lifetime risk perceptions
and mammography screening intentions (within the control arm) were also altered among female
participants. In this study, neither personalized information about risk factors nor improved
accuracy of lifetime risk were associated with changes in intentions to perform risk reducing
behaviors, supporting the old adage that knowledge is necessary but not sufficient to drive
behavior change. Collectively, results support the notion that ‘moving the needle’ in lifestyle
modification toward CRC prevention is difficult – especially among those with no known family
history of the disease. Despite the magnitude of the challenges facing cancer prevention
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researchers, future efforts must continue to develop innovative strategies to prevent CRC as it
remains a fierce threat that must be addressed. Issues related to the prevention paradox will likely
persist until better population approaches to cancer risk communication are developed.
Continued message testing and development is needed related to risk communication, especially
within minority and low numeracy groups. Future studies could use online survey administration
and panel sampling, as findings from this research highlighted the ability of these methods to
produce targeted samples quickly and with reasonable internal validity and external
generalizability.
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APPENDIX

FINAL Dissertation RAQ - for distribution
6.19.17
Start of Block: Consent

Q1 RESEARCH PARTICIPANT INFORMATION AND CONSENT FORM

TITLE: Colorectal Risk Assessment among Average Risk Adults
VCU IRB PROTOCOL NUMBER: HM20009815
INVESTIGATOR: Maria Thomson, PhD
If any information contained in this consent form is not clear, please contact the study staff to
explain any information that you do not fully understand.
PURPOSE OF THE STUDY
The purpose of this research study is to learn more about how people understand and use risk
information about colorectal cancer that is presented in different ways. You are being asked to
participate in this study because you are an adult between 50-75 years of age living in the United
States.
DESCRIPTION OF THE STUDY AND YOUR INVOLVEMENT
This is a survey study. If you decide to be in this research study, you will be asked to click on
the “agree” button to electronically consent after you have had all your questions answered and
understand what will happen to you.
If you agree to participate, you will be randomly assigned to one of two groups. Each group will
answer the same set of questions related to colorectal cancer and receive risk information that
will be presented in one of two ways, depending on your group assignment. After viewing the
risk results, you will be asked to complete a set of follow-up questions. The survey will ask your
opinions about cancer prevention, your attitudes and beliefs related to colorectal cancer
specifically, and related preventive health behaviors and intentions, as well as demographic
questions. The entire survey will take approximately 30 minutes to complete.

121

RISKS AND DISCOMFORTS
There are no physical risks associated with this study. We do not foresee any significant risks or
discomfort to your participation. However, it is possible that some questions could be distressing
to some people, such as questions relating to their personal and family history of cancer. In
addition, participants will receive a numeric risk indicator, which some participants may find
upsetting.
If you choose to participate in this study, please keep in mind that if you do become
uncomfortable and do not wish to answer the survey questions, you may stop at any time by
exiting the survey.
BENEFITS TO YOU AND OTHERS
You may not receive any direct benefits by participating in this research, but you may get the
opportunity and satisfaction of learning more about and contributing to research in this field.
COSTS
There are no costs for participating in this study other than the time you will spend filling out
the online survey.
PAYMENT FOR PARTICIPATION
Survey respondents will receive compensation for participation. You will receive the agreed
upon incentive provided by Qualtrics after completing the survey. There will be no payment for
incomplete surveys, meaning you will not receive compensation if you choose to exit the study
prior to completing the survey in its entirety.
ALTERNATIVES
The alternative to participating in this study is to not participate.
CONFIDENTIALITY
The surveys will be administered online via Qualtrics. Data collected in the survey is completely
anonymous, meaning that there is no way to connect your identity to your responses. Survey data
will be maintained on a HIPAA secured computer and drive; no identifying information or keys
will be included. The results of this study may be used in reports, presentations, or publications,
but your name will not be used.
VOLUNTARY PARTICIPATION AND WITHDRAWAL
Your participation is voluntary. You may decide not to participate in this study. Your decision
not to take part will involve no penalty or loss of benefits to which you are otherwise entitled.
If you choose to participate, you may stop at any time without any penalty. However,
participation involves answering all survey questions, including potentially sensitive questions
(i.e., questions related to their personal and family history of cancer). Thus, you will not receive
compensation if you choose to exit the study prior to completing the survey in its entirety.

122

QUESTIONS
If you have any questions, complaints, or concerns about your participation in this research,
contact the Principal Investigator:
Maria Thomson, PhD at Maria.Thomson@vcuhealth.org.
The researcher named above is the best person to contact for questions about your participation
in this study.
If you have any general questions about your rights as a participant in this or any other research,
you may contact:
Office of Research
Virginia Commonwealth University
800 East Leigh Street, Suite 3000
P.O. Box 980568
Richmond, VA 23298
Telephone: (804) 827-2157
Contact this number for general questions, concerns or complaints about research. You may also
call this number if you cannot reach the research team or if you wish to talk with someone else.
General information about participation in research studies can also be found at
http://www.research.vcu.edu/irb/volunteers.htm.
CONSENT I have been provided with an opportunity to read this consent form carefully.
By clicking the “I consent” button, I have not waived any of the legal rights or benefits, to
which I otherwise would be entitled. My clicking indicates that I freely consent to participate in
this research study.

o I consent (1)
o I do NOT consent (0)
Skip To: End of Block If RESEARCH PARTICIPANT INFORMATION AND CONSENT FORM TITLE: Colorectal Risk
Assessment among Aver... = I do NOT consent

End of Block: Consent
Start of Block: Screening Qs

Q2 Welcome! The following survey is about your attitudes and behaviors related to colorectal
cancer. Colorectal cancer is cancer of the colon (large bowel, large intestine) or rectum. Please
answer each question to the best of your ability. Remember, these questions are about your
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attitudes and behaviors; there are no “right” or “wrong” answers to these questions.
you for taking the time to complete this survey.

Page Break
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Thank

Q3 Are you male or female?

o Male (1)
o Female (0)

Q4 Which of the following categories best describes you?

o White (1)
o Black or African American (2)
o Hispanic, Latino, or Spanish origin (3)
o Some other race, ethnicity, or origin (4)
Skip To: End of Block If Which of the following categories best describes you? = Some other race, ethnicity, or origin

Q5 What is your age (in years)?
________________________________________________________________
Skip To: End of Block If What is your age (in years)? <= 49
Skip To: End of Block If What is your age (in years)? >= 76

Page Break
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Q6 Have you ever been told by a doctor or other healthcare provider that you have polyps in
your colon or rectum? Polyps are small growths that are not cancerous but are often removed to
prevent cancer from developing.

o Yes (1)
o No (0)
Skip To: End of Block If Have you ever been told by a doctor or other healthcare provider that you have polyps in
your col... != No

Q7 Have you ever been told by a doctor or other healthcare provider that you have colon cancer
(cancer of the large bowel, large intestine, or rectum?

o Yes (1)
o No (0)
Skip To: End of Block If Have you ever been told by a doctor or other healthcare provider that you have colon cancer
(canc... != No
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Q8 Please indicate if any of the following statements are true for you:
I have a history of inflammatory bowel disease
(e.g. ulcerative colitis or Crohn’s disease).
(Q8_1)

▼

Yes (1) ... No (2)

At least one of my parents, siblings, or
children has been told they have polyps or
colorectal cancer. (Q8_2)

▼

Yes (1) ... No (2)

I have a known family history of a hereditary
colorectal cancer syndrome such as familial
adenomatous polyposis (FAP) or hereditary
nonpolyposis colon cancer (HNPCC), also
known as Lynch Syndrome. (Q8_3)

▼

Yes (1) ... No (2)

Skip To: End of Block If Please indicate if any of the following statements are true for you: != At least one of my
parents, siblings, or children has been told they have polyps or colorectal cancer.
Skip To: End of Block If Please indicate if any of the following statements are true for you: != At least one of my
parents, siblings, or children has been told they have polyps or colorectal cancer.
Skip To: End of Block If Please indicate if any of the following statements are true for you: != At least one of my
parents, siblings, or children has been told they have polyps or colorectal cancer.
Display This Question:
If Are you male or female? = Female

Q9 Please indicate if any of the following statements are true for you:
I have at least one first-degree relative (e.g.,
mother, sisters, or daughters) who has been
told they have breast cancer. (Q9_1)

▼

Yes (1) ... No (2)

I have a known or suspected mutation in either
the BRCA1 or BRCA2 gene or an inherited
cancer-causing syndrome, such as the LiFraumeni syndrome. (Q9_2)

▼

Yes (1) ... No (2)

127

Q10 Which of the following ranges best describes your household's total income (before taxes)
in the previous year?

o Less than $20,000 (1)
o $20,000 to $49,999 (2)
o $50,000 to $74,999 (3)
o $75,000 to $99,999 (4)
o $100,000 or more (5)
Page Break
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End of Block: Screening Qs
Start of Block: PRE-RP Group 1

Q11
YOU AND COLON CANCER
On a scale from 0 to 100 %, how would you rate the probability that you will develop colorectal
cancer in the future?
________________________________________________________________

Q12
Very unlikely
(1)
How likely is
it that you
will get
colorectal
cancer at
some point in
the future?
(Q12)

o

Unlikely (2)

Neither likely
nor unlikely
(3)

o

o
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Likely (4)

o

Very likely
(5)

o

Q13
Much lower
(1)
How do you
think your
chance of
developing
colorectal
cancer in the
future
compares to
the average
person of
your gender
and age?
(Q13)

o

A little lower
(2)

The same (3)

o

o

A little higher
(4)

o

Much higher
(5)

o

Q14
Very low (1)
The way I
look after my
health means
that my odds
of getting
colorectal
cancer in the
future are:
(Q14)

o

Neither low
nor high (3)

Low (2)

o

o

End of Block: PRE-RP Group 1
Start of Block: PRE-RP Group 2
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High (4)

o

Very High (5)

o

Q15
Not at all (1)

A moderate
amount (3)

A little (2)

A lot (4)

Extremely (5)

How worried
are you about
developing
colorectal
cancer in the
future?
(Q15_1)

o

o

o

o

o

How fearful
are you about
developing
colorectal
cancer in the
future?
(Q15_2)

o

o

o

o

o

How nervous
are you about
developing
colorectal
cancer in
your lifetime?
(Q15_3)

o

o

o

o

o

How
concerned
are you about
developing
colorectal
cancer in
your lifetime?
(Q15_4)

o

o

o

o

o

How easy is
it for you to
imagine
yourself
developing
colorectal
cancer in the
future?
(Q15_5)

o

o

o

o

o
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When you
think about
colorectal
cancer for a
moment, to
what extent
do you feel
fearful?
(Q15_6)

o

o

o

o

o

When you
think about
colorectal
cancer for a
moment, to
what extent
do you feel
worried?
(Q15_7)

o

o

o

o

o

When you
think about
colorectal
cancer for a
moment, to
what extent
do you feel
anxious?
(Q15_8)

o

o

o

o

o

End of Block: PRE-RP Group 2
Start of Block: PRE-RP Group 3
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Q16
Strongly
disagree (1)

Disagree (2)

Neither agree
nor disagree
(3)

Agree (4)

Strongly
agree (5)

When I think
carefully
about my
lifestyle it
does seem
possible that I
could get
colorectal
cancer.
(Q16_1)

o

o

o

o

o

If I look at
myself as if I
were a doctor,
I realize that
my behavior
puts me at
risk of getting
cancer.
(Q16_2)

o

o

o

o

o

I feel very
vulnerable to
colorectal
cancer.
(Q16_3)

o

o

o

o

o

I am
confident that
I will not get
colorectal
cancer.
(Q16_4)

o

o

o

o

o

I would be
lying if I said
“There is no
chance of me
getting
colorectal
cancer.”

o

o

o

o

o
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(Q16_5)
My first
reaction when
I hear of
someone
getting
colorectal
cancer is
“that could be
me
someday.”
(Q16_6)

o

o

o

o

o

End of Block: PRE-RP Group 3
Start of Block: PRE-BCA RP

Q17
YOU AND BREAST CANCER
On a scale from 0 to 100 %, how would you rate the probability that you will develop BREAST
cancer in the future?
________________________________________________________________
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Q18
Very unlikely
(1)
How likely is
it that you
will get
BREAST
cancer at
some point in
the future?
(Q18)

o

Neither likely
nor unlikely
(3)

Unlikely (2)

o

o

Likely (4)

o

Very likely
(5)

o

Q19
Much lower
(1)
How do you
think your
chance of
developing
BREAST
cancer in the
future
compares to
the average
person of
your gender
and age?
(Q19)

o

A little lower
(2)

The same (3)

o

o

End of Block: PRE-BCA RP
Start of Block: PRE-DEM RP
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A little higher
(4)

o

Much higher
(5)

o

Q20
YOU AND DEMENTIA
On a scale from 0 to 100 %, how would you rate the probability that you will develop
DEMENTIA in the future?
________________________________________________________________

Q21
Very unlikely
(1)
How likely is
it that you
will get
DEMENTIA
at some point
in the future?
(Q21)

o

Unlikely (2)

Neither likely
nor unlikely
(3)

o

o
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Likely (4)

o

Very likely
(5)

o

Q22
Much lower
(1)
How do you
think your
chance of
developing
DEMENTIA
in the future
compares to
the average
person of
your gender
and age?
(Q22)

A little lower
(2)

o

The same (3)

o

o

A little higher
(4)

o

Much higher
(5)

o

End of Block: PRE-DEM RP
Start of Block: Screening HX

Q23
CANCER SCREENING TESTS
The next few questions are about some different tests you may have already had to look for
signs of cancer.

Display This Question:
If Are you male or female? = Female
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Q24
A MAMMOGRAM is an x-ray picture of the breast.
Have you ever had a mammogram?

o Yes (1)
o No (0)
o I Don't Know (9)
Display This Question:
If A MAMMOGRAM is an x-ray picture of the breast. Have you ever had a mammogram? = Yes

Q25 When was your most recent mammogram?

o 2 years ago or less (1)
o More than 2 years ago (2)
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Q26
FECAL OCCULT BLOOD TEST (FOBT)

A FOBT IS DONE AT HOME to determine whether your stool contains blood. You take small
samples of your fecal matter or stool and return the sample to be tested.
Have you ever had one of these stool blood tests?

o Yes (1)
o No (0)
o I Don't Know (9)
Display This Question:
If FECAL OCCULT BLOOD TEST (FOBT) A FOBT IS DONE AT HOME to determine whether your stool contains... =
Yes

Q27 When was your most recent FOBT?

o 1 year ago or less (1)
o More than 1 year ago (2)
Page Break
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Q28
The next two questions are about sigmoidoscopy and colonoscopy. Both tests examine the
colon using a narrow, lighted tube that is inserted in the rectum.

Q29
SIGMOIDOSCOPY
A sigmoidoscopy (pronounced: sig-MOY-DAHS-kuh-pee) is also referred to as flexible
sigmoidoscopy or “flex sig.” Sigmoidoscopy examines only the lower part of the colon. You are
awake during the test, can drive yourself home, and can resume normal activities after the
test. Have you ever had a sigmoidoscopy?

o Yes (1)
o No (0)
o I Don't Know (9)
Display This Question:
If SIGMOIDOSCOPY A sigmoidoscopy (pronounced: sig-MOY-DAHS-kuh-pee) is also referred to as flexibl... =
Yes

Q30 When was your most recent sigmoidoscopy?

o 1 year ago or less (1)
o More than 1 but not more than 5 years ago (2)
o More than 5 but not more than 10 years ago (3)
o More than 10 years ago (4)
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Q31
COLONOSCOPY

A colonoscopy (pronounced: koh-luh-NAHS-kuh-pee) is a test that uses a narrow, lighted tube to
examine the entire colon. With a colonoscopy, you are sleepy or asleep during the test, need
someone to drive you home, and need to take the rest of the day off from normal activities.
Have you ever had a colonoscopy?

o Yes (1)
o No (0)
o I Don't Know (9)
Display This Question:
If COLONOSCOPY A colonoscopy (pronounced: koh-luh-NAHS-kuh-pee) is a test that uses a narrow, ligh... =
Yes

Q32 When was your most recent colonoscopy?

o 1 year ago or less (1)
o More than 1 but not more than 5 years ago (2)
o More than 5 but not more than 10 years ago (3)
o More than 10 years ago (4)
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Q33 To make sure you are paying attention, please answer yes for this question.

o Yes (1)
o No (0)
o I Don't Know (9)
Skip To: End of Block If To make sure you are paying attention, please answer yes for this question. != Yes

End of Block: Screening HX
Start of Block: PRE-BI
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Q34
HEALTH BEHAVIORS
Not at all (1)

A moderate
amount (3)

A little (2)

A lot (4)

Extremely (5)

CRCS UTD != 1

How likely
are you to get
tested for
colorectal
cancer in the
next 6
months?
(Q34_1)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

CRCS UTD = 1

How likely
are you to get
tested for
colorectal
cancer (when
you are due
to be tested
again)?
(Q34_2)
Are you male or
female? =
Female
And Mammo
UTD != 1

How likely
are you to get
a
mammogram
in the next 6
months?
(Q34_3)
Are you male or
female? =
Female
And Mammo
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UTD = 1

How likely
are you to get
a
mammogram
(when you
are due to get
a
mammogram
again)?
(Q34_4)
How likely
are you to
improve your
diet in the
next 6
months?
(Q34_5)

o

o

o

o

o

How likely
are you to
increase your
physical
activity in the
next 6
months?
(Q34_6)

o

o

o

o

o

How likely
are you to
talk to a
doctor about
getting tested
for colorectal
cancer in the
next 6
months?
(Q34_7)

o

o

o

o

o

Page Break
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Q35 Do you have a healthy diet?

o YES, I have a healthy diet and I have for MORE than 6 months. (1)
o YES, I have a healthy diet and I have for LESS than 6 months. (2)
o NO, but I intend to improve my diet in the next 30 days. (3)
o NO, but I intend to improve my diet in the next 6 months. (4)
o NO, and I do NOT intend to improve my diet in the next 6 months. (5)

Q36 Are you physically active?

o YES, I am physically active and I have been for MORE than 6 months. (1)
o YES, I am physically active and I have been for LESS than 6 months. (2)
o NO, but I intend to increase my physical activity in the next 30 days. (3)
o NO, but I intend to increase my physical activity in the next 6 months. (4)
o NO, and I do NOT intend to increase my physical activity in the next 6 months. (5)
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Q37 Do you screen for colorectal cancer regularly (as recommended by your healthcare
provider)?

o YES, I screen for colorectal cancer regularly, AND I intend to get screened for colorectal
cancer when I am due again. (1)

o YES, I screen for colorectal cancer regularly, BUT I do NOT intend to get screened for
colorectal cancer when I am due again. (2)

o NO, but I intend to get screened for colorectal cancer in the next 30 days. (3)
o NO, but I intend to get screened for colorectal cancer in the next 6 months. (4)
o NO, and I do NOT intend to get screened for colorectal cancer in the next 6 months. (5)
Display This Question:
If Are you male or female? = Female

Q38 Do you screen for breast cancer regularly (as recommended by your healthcare provider)?

o YES, I screen for breast cancer regularly, AND I intend to get screened for breast cancer
when I am due again. (1)

o YES, I screen for breast cancer regularly, BUT I do NOT intend to get screened for breast
cancer when I am due again. (2)

o NO, but I intend to get screened for breast cancer in the next 30 days. (3)
o NO, but I intend to get screened for breast cancer in the next 6 months. (4)
o NO, and I do NOT intend to get screened for breast cancer in the next 6 months. (5)
End of Block: PRE-BI
Start of Block: Self-Efficacy
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Q39
ATTITUDES AND BELIEFS
Very difficult
(1)

Neither easy
nor difficult
(3)

Difficult (2)

Easy (4)

Very easy (5)

For me,
improving
my diet in
the next 6
months
would be:
(Q39_1)

o

o

o

o

o

For me,
increasing
my physical
activity in the
next 6 months
would be:
(Q39_2)

o

o

o

o

o

For me,
getting
tested for
colorectal
cancer in the
next 6 months
would be:
(Q39_3)

o

o

o

o

o

147

Q40
Strongly
disagree (1)

Disagree (2)

Neither agree
nor disagree
(3)

Agree (4)

Strongly
agree (5)

If I wanted to,
I could easily
improve my
diet in the
next 6
months.
(Q40_1)

o

o

o

o

o

If I wanted to,
I could easily
increase my
physical
activity in the
next 6
months.
(Q40_2)

o

o

o

o

o

If I wanted to,
I could easily
get tested for
colorectal
cancer in the
next 6
months.
(Q40_3)

o

o

o

o

o

End of Block: Self-Efficacy
Start of Block: PRE-Beliefs/AVOID, and NUM
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Q41 How much do you agree or disagree with each of the following statements?
Neither agree
Strongly
Strongly
Disagree (2) nor disagree
Agree (4)
disagree (1)
agree (5)
(3)
Cancer is most
often caused by a
person's behavior
or lifestyle.
(Q41_1)

o

o

o

o

o

It seems like
everything
causes cancer.
(Q41_2)

o

o

o

o

o

There's not much
you can do to
lower your
chances of
getting cancer.
(Q41_3)

o

o

o

o

o

There are so
many different
recommendations
about preventing
cancer, it's hard
to know which
ones to follow.
(Q41_4)

o

o

o

o

o

I'd rather not
know my chance
of getting cancer.
(Q41_5)

o

o

o

o

o

Page Break
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Q42
CHANCE AND PROBABILITIES

Q43
Please answer the following questions to the best of your ability and give your responses in
NUMBERS ONLY - no words or symbols (i.e., 12, not "twelve").

Q44 Imagine that we rolled a fair, six-sided die 1,000 times. Out of 1,000 rolls, how many times
do you think the die would come up even (2, 4, or 6)?
_______ out of 1,000 (1)

Q45 In the BIG BUCKS LOTTERY, the chance of winning a $10 prize is 1%. What is your best
guess about how many people would win a $10 prize if 1,000 people each buy a single ticket to
BIG BUCKS?
_______ people out of 1,000 (1)

Q46 In the ACME PUBLISHING SWEEPSTAKES, the chance of winning a car is 1 in 1,000.
What percent of tickets to ACME PUBLISHING SWEEPSTAKES win a car?
_______ % (1)
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Q47 If the chance of getting a disease is 10%, how many people would be expected to get the
disease:

o Out of 100? (2) ________________________________________________
o Out of 1,000? (3) ________________________________________________
Q48 Timing
First Click (1)
Last Click (2)
Page Submit (3)
Click Count (4)

Page Break
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End of Block: PRE-Beliefs/AVOID, and NUM
Start of Block: CCRAT Items

Q49
ABOUT YOU
What is your height without shoes?

o Feet (1) ________________________________________________
o Inches (2) ________________________________________________

Q50
What is your weight without shoes?

o Pounds (lbs) (1) ________________________________________________

Q51 A drink of alcohol is 1 can or bottle of beer, 1 glass of wine, 1 can or bottle of wine cooler,
1 cocktail, or 1 shot of liquor.
On average, how many days per week do you have at least one drink of any alcoholic beverage?
________________________________________________________________

Display This Question:
If If A drink of alcohol is 1 can or bottle of beer, 1 glass of wine, 1 can or bottle of wine cooler, 1 cocktail, or 1
shot of liquor.&nbsp; &nbsp; During the past 30 days, how many days per week did yo... Text Response Is Not
Equal to 0
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Q52 On days when you drink, about how many drinks do you have on the average?
________________________________________________________________

Page Break
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Q53 In your entire lifetime, altogether, have you smoked 100 or more cigarettes?

o Yes (1)
o No (0)
o I don't know (9)
Display This Question:
If In your entire lifetime, altogether, have you smoked 100 or more cigarettes? = Yes

Q54 How old were you when you started smoking cigarettes on a regular basis, that is, at least
one cigarette a day for six months or longer?
▼ I have never smoked cigarettes regularly. (1) ... 54 (50)

Display This Question:
If How old were you when you started smoking cigarettes on a regular basis, that is, at least one ci... , I have
never smoked cigarettes regularly. Is Displayed
And How old were you when you started smoking cigarettes on a regular basis, that is, at least one ci... != I
have never smoked cigarettes regularly.

Q55 Do you currently smoke cigarettes?

o Yes (1)
o No (0)
Display This Question:
If Do you currently smoke cigarettes? = No

Q56 How old were you when you quit smoking cigarettes completely?
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NOTE: If you quit smoking cigarettes completely more than one time, please tell us how old you
were the last time you quit smoking completely.

▼ 16 (1) ... 54 (39)

Display This Question:
If How old were you when you started smoking cigarettes on a regular basis, that is, at least one ci... , I have
never smoked cigarettes regularly. Is Displayed
And How old were you when you started smoking cigarettes on a regular basis, that is, at least one ci... != I
have never smoked cigarettes regularly.

Q57 Thinking back over the years you have smoked regularly, about how many cigarettes have
you usually smoked a day?

o 1 to 10 cigarettes a day (1)
o 11 to 20 cigarettes a day (2)
o More than 20 cigarettes a day (3)
Page Break
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Q58
Vegetables INCLUDE raw, cooked, canned, and frozen vegetables (including beans) and leafy
green salads. DO NOT INCLUDE fried vegetables like French fries or fried potatoes.
In the past 30 days, about how many servings per week of vegetables or leafy green salads did
you eat?

o None (1)
o Less than 1 serving per week (2)
o 1-2 servings per week (3)
o 3-4 servings per week (4)
o 5-6 servings per week (5)
o 7-10 servings per week (6)
o More than 10 servings per week (7)
Display This Question:
If Vegetables INCLUDE raw, cooked, canned, and frozen vegetables (including beans) and leafy green s... !=
None
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Q59 In the past 30 days, how much did you usually eat in each serving of vegetables or leafy
green salads?

o 1/2 cup or less (1)
o Between 1/2 cup and 1 1/2 cups (2)
o Between 1 1/2 cups and 3 cups (3)
o Between 3 cups and 5 cups (4)
o More than 5 cups (5)
Page Break
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Q60
Moderate physical activities DO NOT cause you to sweat or breathe hard. Some examples
include vacuuming, gardening, easy walking for exercise, and so on.

In a typical week, how many days, if any, did you do any kind of moderate physical activity?
________________________________________________________________

Display This Question:
If If Moderate physical activities DO NOT cause you to sweat or breathe hard. Some examples include va... Text
Response Is Not Equal to 0

Q61 During those days, on average, about how many minutes per day did you do moderate
physical activities?
________________________________________________________________

Page Break
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Q62
Vigorous activities include all activities that DO cause you to sweat or breathe hard. Some
examples include racquet sports, basketball, running, fast biking, exercise class, weight
lifting, backpacking, swimming, and heavy labor such as shoveling dirt.

In a typical week, how many days, if any, did you do any kind of vigorous physical activity?
________________________________________________________________

Display This Question:
If If Vigorous activities include all activities that DO cause you to sweat or breathe hard. Some exam... Text
Response Is Not Equal to 0

Q63 During those days, on average, about how many minutes per day did you do
vigorous physical activities?
________________________________________________________________

Page Break
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Q64 To confirm that your responses in the survey are valid, please select disagree for this
question.

o Strongly agree (4)
o Agree (5)
o Somewhat agree (6)
o Neither agree nor disagree (7)
o Somewhat disagree (8)
o Disagree (9)
o Strongly disagree (10)
Skip To: End of Block If To confirm that your responses in the survey are valid, please select disagree for this
question. != Disagree

Page Break
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Q65
During the past 30 days, have you taken medications containing aspirin at least 3 times a week,
such as:
- Bufferin
- Bayer
- Excedrin
- Other generic form
NOTE: Do NOT include TYLENOL

o Yes (1)
o No (0)
o I Don't Know (9)

Q66
During the past 30 days, have you taken medications that do NOT contain aspirin at least 3
times a week, such as:
- Advil
- Aleve
- Celebrex
- Ibuprofen
- Motrin
- Naproxen
- Nuprin
NOTE: Do NOT include TYLENOL

o Yes (1)
o No (0)
o I Don't Know (9)
Page Break
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Display This Question:
If Are you male or female? = Female

Q67 Do you still have periods?

o Yes (1)
o No (0)
Display This Question:
If Do you still have periods? = No

Q68
When did you have your last period?

o 1 year ago or less (1)
o More than 1 year ago but less than 2 years ago (2)
o 2 years ago or more (3)
Display This Question:
If When did you have your last period? = 2 years ago or more
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Q69
During the past 2 years, have you used estrogen, progestin, or other female hormones?
These hormones may be given as hormone pills, oral contraceptives, shots, skin patches, vaginal
creams, or as vaginal suppositories.

o Yes (1)
o No (0)
Page Break
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End of Block: CCRAT Items
Start of Block: MEN - INT MSG

Q70
Your Colorectal Cancer Risk Summary

*** PLEASE REVIEW THE FOLLOWING INFORMATION CAREFULLY ***

Estimates are not exact. Your risk for developing colorectal cancer during your lifetime may be
higher or lower.

Q71 Timing
First Click (1)
Last Click (2)
Page Submit (3)
Click Count (4)

Page Break
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Q72
Your Colorectal Cancer Risk Summary

*** PLEASE REVIEW THE FOLLOWING INFORMATION CAREFULLY ***

Although average risk for colorectal cancer is only about 5%, this is just an estimate. An
individual's risk of developing cancer can be affected by lifestyle choices. The personalized
health messages below are based on your answers to this survey:
[Men Intervention Message]

Q73
Not at all
carefully (1)
To what
extent did
you carefully
review the
information
on this page?
(Q73_1)

o

Slightly
carefully (2)

Somewhat
carefully (3)

o

o

Q74 Timing
First Click (1)
Last Click (2)
Page Submit (3)
Click Count (4)
End of Block: MEN - INT MSG
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Moderately
carefully (4)

o

Very
carefully (5)

o

Start of Block: MEN - CON MSG

Q75
Your Colorectal Cancer Risk Summary

*** PLEASE REVIEW THE FOLLOWING INFORMATION CAREFULLY ***

Estimates are not exact. Your risk for developing colorectal cancer during your lifetime may be
higher or lower.

Q76 Timing
First Click (1)
Last Click (2)
Page Submit (3)
Click Count (4)

Page Break
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Q77
Your Colorectal Cancer Risk Summary

*** PLEASE REVIEW THE FOLLOWING INFORMATION CAREFULLY ***

Although the average lifetime risk for colorectal cancer is only about 5%, this is just an
estimate. An individual's risk of developing cancer can be affected by lifestyle choices.
Factors that can make your risk of colorectal cancer higher include:
(parents, brothers, sisters, or children) who have had colorectal cancer
polyps Obesity
Cigarette smoking
Inactive lifestyle

Close relatives
History of colorectal

Factors that can lower your risk of colorectal cancer include:
Colorectal cancer screening
Regular use of aspirin and NSAID’s Maintaining a healthy weight Regular, vigorous
exercise (all activities that cause sweating and heavy breathing)
A diet high in vegetables
Hormone replacement therapy use in women

Q78
Not at all
carefully (1)
To what
extent did
you carefully
review the
information
on this page?
(1)

o

Slightly
carefully (2)

Somewhat
carefully (3)

o

o
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Moderately
carefully (4)

o

Very
carefully (5)

o

Q79 Timing
First Click (1)
Last Click (2)
Page Submit (3)
Click Count (4)
End of Block: MEN - CON MSG
Start of Block: WOMEN - INT MSG

Q80
Your Colorectal Cancer Risk Summary

*** PLEASE REVIEW THE FOLLOWING INFORMATION CAREFULLY ***

Estimates are not exact. Your risk for developing colorectal cancer during your lifetime may be
higher or lower.

Q81 Timing
First Click (1)
Last Click (2)
Page Submit (3)
Click Count (4)

Page Break
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Q82
Your Colorectal Cancer Risk Summary

*** PLEASE REVIEW THE FOLLOWING INFORMATION CAREFULLY ***

Although average risk for colorectal cancer is only about 5%, this is just an estimate. An
individual's risk of developing cancer can be affected by lifestyle choices. The personalized
health messages below are based on your answers to this survey:
[Women Intervention Message]

Q83
Not at all
carefully (1)
To what
extent did
you carefully
review the
information
on this page?
(1)

o

Slightly
carefully (2)

Somewhat
carefully (3)

o

o

Q84 Timing
First Click (1)
Last Click (2)
Page Submit (3)
Click Count (4)
End of Block: WOMEN - INT MSG
Start of Block: WOMEN - CON MSG
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Moderately
carefully (4)

o

Very
carefully (5)

o

Q85
Your Colorectal Cancer Risk Summary

*** PLEASE REVIEW THE FOLLOWING INFORMATION CAREFULLY ***

Estimates are not exact. Your risk for developing colorectal cancer during your lifetime may be
higher or lower.

Q86 Timing
First Click (1)
Last Click (2)
Page Submit (3)
Click Count (4)

Page Break
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Q87
Your Colorectal Cancer Risk Summary

*** PLEASE REVIEW THE FOLLOWING INFORMATION CAREFULLY ***

Although the average lifetime risk for colorectal cancer is only about 5%, this is just an
estimate. An individual's risk of developing cancer can be affected by lifestyle choices.
Factors that can make your risk of colorectal cancer higher include:
(parents, brothers, sisters, or children) who have had colorectal cancer
polyps Obesity
Cigarette smoking
Inactive lifestyle

Close relatives
History of colorectal

Factors that can lower your risk of colorectal cancer include:
Colorectal cancer screening
Regular use of aspirin and NSAID’s Maintaining a healthy weight Regular, vigorous
exercise (all activities that cause sweating and heavy breathing)
A diet high in vegetables
Hormone replacement therapy use in women

Q88
Not at all
carefully (1)
To what
extent did
you carefully
review the
information
on this page?
(1)

o

Slightly
carefully (2)

Somewhat
carefully (3)

o

o
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Moderately
carefully (4)

o

Very
carefully (5)

o

Q89 Timing
First Click (1)
Last Click (2)
Page Submit (3)
Click Count (4)
End of Block: WOMEN - CON MSG
Start of Block: POST-RP Group 1

Q90
YOU AND COLON CANCER
On a scale from 0 to 100 %, how would you rate the probability that you will develop colorectal
cancer in the future?
________________________________________________________________

Q91
Very unlikely
(1)
How likely is
it that you
will get
colorectal
cancer at
some point in
the future?
(Q91)

o

Unlikely (2)

Neither likely
nor unlikely
(3)

o

o
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Likely (4)

o

Very likely
(5)

o

Q92
Much lower
(1)
How do you
think your
chance of
developing
colorectal
cancer in the
future
compares to
the average
person of
your gender
and age?
(Q92)

o

A little lower
(2)

The same (3)

o

o

A little higher
(4)

o

Much higher
(5)

o

Q93
Very low (1)
The way I
look after my
heath means
that my odds
of getting
colorectal
cancer in the
future are:
(Q93)

o

Neither low
nor high (3)

Low (2)

o

o

End of Block: POST-RP Group 1
Start of Block: POST-RP Group 2
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High (4)

o

Very high (5)

o

Q94
Not at all (1)

A moderate
amount (3)

A little (2)

A lot (4)

Extremely (5)

How worried
are you about
developing
colorectal
cancer in the
future?
(Q94_1)

o

o

o

o

o

How fearful
are you about
developing
colorectal
cancer in the
future?
(Q94_2)

o

o

o

o

o

How nervous
are you about
developing
colorectal
cancer in
your lifetime?
(Q94_3)

o

o

o

o

o

How
concerned
are you about
developing
colorectal
cancer in
your lifetime?
(Q94_4)

o

o

o

o

o

How easy is
it for you to
imagine
yourself
developing
colorectal
cancer in the
future?
(Q94_5)

o

o

o

o

o
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When you
think about
colorectal
cancer for a
moment, to
what extent
do you feel
fearful?
(Q94_6)

o

o

o

o

o

When you
think about
colorectal
cancer for a
moment, to
what extent
do you feel
worried?
(Q94_7)

o

o

o

o

o

When you
think about
colorectal
cancer for a
moment, to
what extent
do you feel
anxious?
(Q94_8)

o

o

o

o

o

End of Block: POST-RP Group 2
Start of Block: POST-RP Group 3
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Q95
Strongly
disagree (1)

Disagree (2)

Neither agree
nor disagree
(3)

Agree (4)

Strongly
agree (5)

When I think
carefully
about my
lifestyle it
does seem
possible that I
could get
colorectal
cancer.
(Q95_1)

o

o

o

o

o

If I look at
myself as if I
was a doctor,
I realize that
my behavior
puts me at
risk of getting
cancer.
(Q95_2)

o

o

o

o

o

I feel very
vulnerable to
colorectal
cancer.
(Q95_3)

o

o

o

o

o

I am
confident that
I will not get
colorectal
cancer.
(Q95_4)

o

o

o

o

o

I would be
lying if I said
“There is no
chance of me
getting
colorectal
cancer.”

o

o

o

o

o
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(Q95_5)
My first
reaction when
I hear of
someone
getting
colorectal
cancer is
“that could be
me
someday.”
(Q95_6)

o

o

o

o

o

End of Block: POST-RP Group 3
Start of Block: POST-BCA RP

Q96
YOU AND BREAST CANCER
On a scale from 0 to 100 %, how would you rate the probability that you will develop BREAST
cancer in the future?
________________________________________________________________
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Q97
Very unlikely
(1)
How likely is
it that you
will get
BREAST
cancer at
some point in
the future?
(Q97)

o

Neither likely
nor unlikely
(3)

Unlikely (2)

o

o

Likely (4)

o

Very likely
(5)

o

Q98
Much lower
(1)
How do you
think your
chance of
developing
BREAST
cancer in the
future
compares to
the average
person of
your gender
and age?
(Q98)

o

A little lower
(2)

The same (3)

o

o

End of Block: POST-BCA RP
Start of Block: POST-DEM RP
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A little higher
(4)

o

Much higher
(5)

o

Q99
YOU AND DEMENTIA
On a scale from 0 to 100 %, how would you rate the probability that you will develop
DEMENTIA in the future?
________________________________________________________________

Q100
Very unlikely
(1)
How likely is
it that you
will get
DEMENTIA
at some point
in the future?
(Q100)

o

Unlikely (2)

Neither likely
nor unlikely
(3)

o

o
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Likely (4)

o

Very likely
(5)

o

Q101
Much lower
(1)
How do you
think your
chance of
developing
DEMENTIA
in the future
compares to
the average
person of
your gender
and age?
(Q101)

o

A little lower
(2)

The same (3)

o

o

End of Block: POST-DEM RP
Start of Block: POST-BI
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A little higher
(4)

o

Much higher
(5)

o

Q102
HEALTH BEHAVIORS
Not at all (1)

A moderate
amount (3)

A little (2)

A lot (4)

Extremely (5)

CRCS UTD != 1

How likely
are you to get
tested for
colorectal
cancer in the
next 6
months?
(Q102_1)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

CRCS UTD = 1

How likely
are you to get
tested for
colorectal
cancer (when
you are due
to be tested
again)?
(Q102_2)
Are you male or
female? =
Female
And Mammo
UTD != 1

How likely
are you to get
a
mammogram
in the next 6
months?
(Q102_3)
Are you male or
female? =
Female
And Mammo

181

UTD = 1

How likely
are you to get
a
mammogram
(when you
are due to get
a
mammogram
again?
(Q102_4)
How likely
are you to
improve your
diet in the
next 6
months?
(Q102_5)

o

o

o

o

o

How likely
are you to
increase your
physical
activity in the
next 6
months?
(Q102_6)

o

o

o

o

o

How likely
are you to
talk to a
doctor about
getting tested
for colorectal
cancer in the
next 6
months?
(Q102_7)

o

o

o

o

o

Page Break

182

Q103 Do you have a healthy diet?

o YES, I have a healthy diet and I have for MORE than 6 months. (1)
o YES, I have a healthy diet and I have for LESS than 6 months. (2)
o NO, but I intend to improve my diet in the next 30 days. (3)
o NO, but I intend to improve my diet in the next 6 months. (4)
o NO, and I do NOT intend to improve my diet in the next 6 months. (5)

Q104 Are you physically active?

o YES, I am physically active and I have been for MORE than 6 months. (1)
o YES, I am physically active and I have been for LESS than 6 months. (2)
o NO, but I intend to increase my physical activity in the next 30 days. (3)
o NO, but I intend to increase my physical activity in the next 6 months. (4)
o NO, and I do NOT intend to increase my physical activity in the next 6 months. (5)
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Q105 Do you screen for colorectal cancer regularly (as recommended by your healthcare
provider)?

o YES, I screen for colorectal cancer regularly, AND I intend to get screened for colorectal
cancer when I am due again. (1)

o YES, I screen for colorectal cancer regularly, BUT I do NOT intend to get screened for
colorectal cancer when I am due again. (2)

o NO, but I intend to get screened for colorectal cancer in the next 30 days. (3)
o NO, but I intend to get screened for colorectal cancer in the next 6 months. (4)
o NO, and I do NOT intend to get screened for colorectal cancer in the next 6 months. (5)
Display This Question:
If Are you male or female? = Female

Q106 Do you screen for breast cancer regularly (as recommended by your healthcare provider)?

o YES, I screen for breast cancer regularly, AND I intend to get screened for breast cancer
when I am due again. (1)

o YES, I screen for breast cancer regularly, BUT I do NOT intend to get screened for breast
cancer when I am due again. (2)

o NO, but I intend to get screened for breast cancer in the next 30 days. (3)
o NO, but I intend to get screened for breast cancer in the next 6 months. (4)
o NO, and I do NOT intend to get screened for breast cancer in the next 6 months. (5)
End of Block: POST-BI
Start of Block: POST-Beliefs/AVOID
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Q107 ATTITUDES AND BELIEFS
following statements?
Strongly
disagree (1)

How much do you agree or disagree with each of the

Disagree (2)

Neither agree
nor disagree
(3)

Agree (4)

Strongly
agree (5)

Cancer is most
often caused by a
person's behavior
or lifestyle.
(Q107_1)

o

o

o

o

o

It seems like
everything
causes cancer.
(Q107_2)

o

o

o

o

o

There's not much
you can do to
lower your
chances of
getting cancer.
(Q107_3)

o

o

o

o

o

There are so
many different
recommendations
about preventing
cancer, it's hard
to know which
ones to follow.
(Q107_4)

o

o

o

o

o

I'd rather not
know my chance
of getting cancer.
(Q107_5)

o

o

o

o

o

End of Block: POST-Beliefs/AVOID
Start of Block: Knowledge
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Q108 Please indicate whether each of the following either increases, decreases, or does not
affect risk for colorectal cancer:
Do Not Affect Risk
Increases Risk (1)
Decreases Risk (2)
(3)
Being older than 49
years old (>= 50)
(Q108_1)

o

o

o

Getting screened for
colorectal cancer
(Q108_2)

o

o

o

Having a family
history of colorectal
cancer (Q108_3)

o

o

o

o
o
o

o
o
o

o
o
o

Eating more than 3
servings of red meat a
week (Q108_7)

o

o

o

Engaging in at least
30 minutes of
physical activity a day
(Q108_8)

o

o

o

Please select
decreases risk for this
statement (Q108_attn)

o

o

o

Taking aspirin daily
(Q108_9)

o

o

o

Eating less than 5
servings of fruits and
vegetables a day
(Q108_10)

o

o

o

Having a colorectal
polyp (Q108_4)
Stress (Q108_5)
Obesity (Q108_6)
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Smoking (Q108_11)

o

o

o

Drinking more than
one serving of alcohol
each day (Q108_12)

o

o

o

End of Block: Knowledge
Start of Block: Saliency

Q109 How much do you think health behaviors such as diet, exercise, and screening tests
determine whether or not a person will develop colorectal cancer?
A moderate
Completely
Not at all (1)
A little (2)
A lot (4)
amount (3)
(5)
(Q109)

o

o

o
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o

o

Q110
Improving my diet would be:
Strongly
disagree (1)
Important
(Q110_1)
Worthless
(Q110_2)
Wise
(Q110_3)
Beneficial
(Q110_4)
Bad/Negative
(Q110_5)

o
o
o
o
o

Neither agree
nor disagree
(3)

Disagree (2)

o
o
o
o
o

o
o
o
o
o

Agree (4)

o
o
o
o
o

Strongly
agree (5)

o
o
o
o
o

Q111 Increasing my physical activity would be:
Strongly
disagree (1)
Important
(Q111_1)
Worthless
(Q111_2)
Wise
(Q111_3)
Beneficial
(Q111_4)
Bad/Negative
(Q111_5)

o
o
o
o
o

Disagree (2)

Neither agree
nor disagree
(3)

o
o
o
o
o

o
o
o
o
o
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Agree (4)

o
o
o
o
o

Strongly
agree (5)

o
o
o
o
o

Q112 Being tested for colorectal cancer would be:
Neither agree
Strongly
Disagree (2)
nor disagree
disagree (1)
(3)
Important
(Q112_1)
Worthless
(Q112_2)
Wise
(Q112_3)
Beneficial
(Q112_4)
Bad/Negative
(Q112_5)

o
o
o
o
o

o
o
o
o
o

o
o
o
o
o

End of Block: Saliency
Start of Block: PERC CONSEQ And PERC Control
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Agree (4)

o
o
o
o
o

Strongly
agree (5)

o
o
o
o
o

Q113 Indicate your level of agreement with the following statements:
Neither agree
Strongly
Disagree (2)
nor disagree
Agree (4)
disagree (1)
(3)

Strongly
agree (5)

Improving
my diet
would lower
my risk of
getting
colorectal
cancer.
(Q113_1)

o

o

o

o

o

Exercising
more would
lower my
risk of
getting
colorectal
cancer.
(Q113_2)

o

o

o

o

o

Being tested
for colorectal
cancer would
lower my
risk of
getting it.
(Q113_3)

o

o

o

o

o
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Q114
Strongly
disagree (1)

Disagree (2)

Neither agree
nor disagree
(3)

Agree (4)

Strongly
agree (5)

There are
things I can
do to control
whether I get
colorectal
cancer or not.
(Q114_1)

o

o

o

o

o

What I do
can
determine
whether I get
colorectal
cancer or not.
(Q114_2)

o

o

o

o

o

My actions
will have no
effect on
whether I get
colorectal
cancer or not.
(Q114_3)

o

o

o

o

o

Nothing I do
will affect
my colorectal
cancer risk.
(Q114_4)

o

o

o

o

o

End of Block: PERC CONSEQ And PERC Control
Start of Block: Demographics

Q115
PLEASE TELL US ABOUT YOURSELF
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What language do you usually speak at home?

o English (1)
o Spanish (2)
o Other (3)

Q116 What is the highest level of education you completed?
▼ Less than high school or some high school (1) ... Master's degree or higher (6)

Q117 What is your employment status?
▼ Employed full-time (1) ... Disability (6)

Q118 What is your marital status?
▼ Never married (1) ... Widowed (4)

Q119 In general, how would you describe your health?
▼ Excellent (1) ... Poor (5)
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Q120 How confident are you filling out medical forms by yourself?
▼ Extremely (1) ... Not at all (5)

Q121 Do you have any kind of health care coverage, including health insurance obtained through
employment or purchased directly, as well as government programs like Medicare and
Medicaid?

o Yes (1)
o No (0)

Q122 Do you have one person you think of as your personal doctor or healthcare provider?

o Yes (1)
o No (0)
Display This Question:
If Do you have one person you think of as your personal doctor or healthcare provider? = Yes

Q123 What type of health care provider is this person?
▼ Primary or general care physician (1) ... Other (4)
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Display This Question:
If Are you male or female? = Female

Q124 Have you ever been told by a doctor or other healthcare provider that you have breast
cancer, ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS)?

o Yes (1)
o No (0)
Display This Question:
If Are you male or female? = Female

Q125 Have you ever been told by a doctor or other healthcare provider that you have any
OTHER type of cancer?

o Yes (1)
o No (0)
Display This Question:
If Are you male or female? = Male

Q126 Have you ever been told by a doctor or other healthcare provider that you have any type of
cancer?

o Yes (1)
o No (0)
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Display This Question:
If Have you ever been told by a doctor or other healthcare provider that you have any type of cancer? = Yes
Or Have you ever been told by a doctor or other healthcare provider that you have any OTHER type of... = Yes

Q127 What type of cancer were you told you have?
________________________________________________________________

Q128 In which state do you currently reside?
▼ Alabama (1) ... I do not reside in the United States (99)

End of Block: Demographics
Start of Block: Quality/COM HYP/Next Steps
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Q129
FINAL QUESTION SET

The information you received about your estimated risk (%) of getting colon cancer was…?
1 (1)
2 (2)
3 (3)
4 (4)
5 (5)
Not
Relevant
Not Useful
Not
Informative
Not
Credible
Not
Accurate
Too much
information
Hard to
Understand
Too little
information

o
o
o
o
o
o
o
o

o
o
o
o
o
o
o
o

o
o
o
o
o
o
o
o
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o
o
o
o
o
o
o
o

o
o
o
o
o

Informative

o

Right
amount of
information

o

Easy to
Understand

o

Right
amount of
information

Relevant
Useful

Credible
Accurate

Q130
The information you received about what can lower your risk of colon cancer was…?
1 (1)
2 (2)
3 (3)
4 (4)
5 (5)
Not
Relevant
Not Useful
Not
Informative
Not
Credible
Not
Accurate
Too much
information
Hard to
Understand
Too little
information

o
o
o
o
o
o
o
o

o
o
o
o
o
o
o
o

o
o
o
o
o
o
o
o

Page Break
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o
o
o
o
o
o
o
o

o
o
o
o
o

Informative

o

Right
amount of
information

o

Easy to
Understand

o

Right
amount of
information

Relevant
Useful

Credible
Accurate

Q131 Based on the colorectal cancer risk information you received, please indicate your level
of interest in the following activities:
Not
Slightly
Moderately
Very
Extremely
interested at
interested (2) interested (3) interested (4) interested (5)
all (1)
Getting
assistance with
goal setting to
address
identified
health risks
(Q131_1)

o

o

o

o

o

Discussing
your health
risk with
doctor or
healthcare
provider
(Q131_2)

o

o

o

o

o

Learning
about
colorectal
cancer
screening
programs in
your
community
(Q131_3)

o

o

o

o

o

Learning
about fitness
programs (i.e.,
walking
groups) in
your
community
(Q131_4)

o

o

o

o

o

Receiving
health risk
information
related to other
conditions

o

o

o

o

o
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(i.e.,
cardiovascular
disease)
(Q131_5)
Participating
in clinical
trials to reduce
your risk
(Q131_6)

o

o

o

o

o

Learning
about nutrition
assistance (i.e.,
diet guidance)
in your
community
(Q131_7)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

Are you male or
female? = Female

Learning
about
mammography
screening
programs in
your
community
(Q131_8)
Participating
in health
programs in
your
workplace
(Q131_9)

End of Block: Quality/COM HYP/Next Steps
Start of Block: Goodbye
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Q132
The colorectal cancer risk estimate provided to you in this survey was the average lifetime risk
for someone your gender living in the United States. If you are interested in learning more about
your personal risk, please visit the following website:
https://www.cancer.gov/colorectalcancerrisk/Default.aspx
For more information about colon cancer:
American Cancer Society: https://www.cancer.org/cancer/colon-rectal-cancer.html
Centers for Disease Control and Prevention: https://www.cdc.gov/cancer/colorectal/
Mayo Clinic: http://www.mayoclinic.org/diseases-conditions/colon-cancer/home/ovc-20188216
National Cancer Institute: https://www.cancer.gov/types/colorectal
End of Block: Goodbye
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